Poisons and Drugs (Amendment) Act 1991 (ACT)

AUSTRALIAN CAPITAL TERRITORY

Poisons and Drugs (Amendment) Act 1991

No. 4 of 1991

An Act to amend the Poisons and Drugs Act 1978

[Notified in ACT Gazette S7: 1 March 1991]

The Legislative Assembly for the Australian Capital Territory enacts as follows:

Short title

1.  This Act may be cited as the Poisons and Drugs (Amendment) Act 1991.

Commencement

2.  (1)  Sections 1, 2 and 3 commence on the day on which this Act is notified in the Gazette.

(2)  The remaining provisions commence on a day, or respective days, fixed by the Minister by notice in the Gazette.

(3)  If a provision referred to in subsection (2) has not commenced before the end of the period of 6 months commencing on the day on which this Act is notified in the Gazette, that provision, by force of this subsection, commences on the first day after the end of that period.

Principal Act

3.  In this Act, “Principal Act” means the Poisons and Drugs Act 1978.1

Substitution

4.  Schedules 1 to 7, inclusive, to the Principal Act are repealed and the following Schedules substituted:

SCHEDULE 1  Section 3

Aconite (Aconitum spp)

Comfrey (Symphytum spp) for human internal use, being—

(a)any preparation; or

(b)any part of the dried plant

Croton oil

Savin, oil of

Tansy, oil of

SCHEDULE 2  Section 3

Acetic acid (excluding its salts and derivatives) in preparations containing more than 80% of acetic acid, for therapeutic use

Aloxiprin

Antazoline in eye drops

Aspirin, except—

(a)when included in Schedule 4 or 6;

(b)in individually wrapped powders or sachets of granules each containing 650 mg or less of aspirin as the only therapeutically active constituent, other than effervescent agents, when enclosed in a primary pack that—

(i)contains not more than 12 such powders or sachets of granules;

(ii)is labelled—

“WARNING—THIS MEDICATION MAY BE DANGEROUS WHEN USED IN LARGE AMOUNTS OR FOR A LONG PERIOD”; or

“CAUTION—THIS PREPARATION IS FOR THE RELIEF OF MINOR AND TEMPORARY AILMENTS AND SHOULD BE USED STRICTLY AS DIRECTED.  PROLONGED USE WITHOUT MEDICAL SUPERVISION COULD BE HARMFUL”; and

(iii)includes in the directions for use, in capital letters not less than 1.5 mm in height, the warning statements—

“CONSULT A DOCTOR BEFORE GIVING THIS MEDICINE TO CHILDREN OR TEENAGERS WITH CHICKEN POX, INFLUENZA OR FEVER”; and

“CAUTION—DO NOT GIVE TO CHILDREN UNDER 2 YEARS OF AGE EXCEPT ON DOCTOR’S ADVICE”; or

(c)in tablets or capsules each containing 325 mg or less of aspirin as the only therapeutically active constituent, other than effervescent agents, when—

(i)packed in blister or strip packaging or in containers with a child‑resistant closure;

(ii)in a primary pack containing not more than 25 such tablets or capsules;

(iii)the pack is labelled—

“WARNING—THIS MEDICATION MAY BE DANGEROUS WHEN USED IN LARGE AMOUNTS OR FOR A LONG PERIOD”; or

“CAUTION—THIS PREPARATION IS FOR THE RELIEF OF MINOR AND TEMPORARY AILMENTS AND SHOULD BE USED STRICTLY AS DIRECTED.  PROLONGED USE WITHOUT MEDICAL SUPERVISION COULD BE HARMFUL”; and

(iv)includes in the directions for use, in capital letters not less than 1.5 mm in height, the warning statements—

“CONSULT A DOCTOR BEFORE GIVING THIS MEDICINE TO CHILDREN OR TEENAGERS WITH CHICKEN POX, INFLUENZA OR FEVER”; and

“CAUTION—DO NOT GIVE TO CHILDREN UNDER 2 YEARS OF AGE EXCEPT ON DOCTOR’S ADVICE”

Atropine (excluding atropine methonitrate)—

(a)in preparations containing 0.25% or less of atropine; or

(b)atropine sulphate, 0.6 mg tablets in packs of six, when labelled for treatment of organophosphorus poisoning

Belladonna in preparations containing 0.25% or less of the alkaloids of belladonna, calculated as hyoscyamine

Benzamine when included in—

(a)lozenges, pastilles, tablets or capsules containing 30 mg or less of benzamine in each;

(b)suppositories or bougies containing 200 mg or less of benzamine in each; or

(c)preparations for topical use, other than eye drops, containing 10% or less of benzamine

Benzocaine when included in—

(a)lozenges, pastilles, tablets or capsules containing 30 mg or less of benzocaine in each;

(b)suppositories or bougies containing 200 mg or less of benzocaine in each; or

(c)preparations for topical use, other than eye drops, containing 10% or less of benzocaine

Benzoyl peroxide in preparations for external human therapeutic use containing 5% or less of benzoyl peroxide

Benzydamine in preparations for topical use containing 3% or less of benzydamine

Bromhexine

Brompheniramine in oral preparations when compounded with one or more of the following medicaments:

(a)an antitussive, except codeine or dihydrocodeine;

(b)an expectorant;

(c)a sympathomimetic amine;

except in preparations for the treatment of children under 2 years of age

Buclizine in primary packs of 10 doses or less, for the prevention or treatment of motion sickness

Butylaminobenzoate when included in—

(a)lozenges, pastilles, tablets or capsules containing 30 mg or less of butylaminobenzoate in each;

(b)suppositories or bougies containing 200 mg or less of butylaminobenzoate in each; or

(c)preparations for topical use, other than eye drops, containing 10% or less of butylaminobenzoate

Carbaryl in preparations for external human therapeutic use containing 2% or less of carbaryl

Carbenoxolone for topical oral use

Carbetapentane, except in preparations containing 0.5% or less of carbetapentane

Chloroform in preparations for therapeutic use, except—

(a)when included in Schedule 4; or

(b)in preparations containing 0.5% or less of chloroform

Chlorpheniramine in oral preparations when compounded with one or more of the following medicaments:

(a)an antitussive, except codeine or dihydrocodeine;

(b)an expectorant;

(c)a sympathomimetic amine;

except in preparations for the treatment of children under 2 years of age

Cinnamedrine

Clioquinol and other halogenated derivatives of 8-hydroxyquinoline for external human use

Codeine—

(a)when compounded with aspirin, paracetamol or any one of their derivatives, in dosage units each containing 10 mg or less of codeine and no other analgesic substance, and—

(i)in tablets or capsules when packed in blister or strip packaging or in a container with a child-resistant closure; or

(ii)in individually wrapped powders;

and in a primary pack containing 25 or less dosage units; or

(b)when compounded with one or more other therapeutically active substances—

(i)in divided preparations containing 10 mg or less of codeine and with a recommended dose not exceeding 15 mg of codeine; or

(ii)in undivided preparations containing 0.25% or less of codeine and with a recommended dose not exceeding 15 mg of codeine

Creosote derived from wood, for human therapeutic use, except in preparations containing 3% or less of phenols included in this Schedule

Cyanides—see Hydrocyanic acid

DDT—see Dicophane

Dexchlorpheniramine in oral preparations when compounded with one or more of the following medicaments:

(a)an antitussive, except codeine or dihydrocodeine;

(b)an expectorant;

(c)a sympathomimetic amine;

except in preparations for the treatment of children under 2 years of age

Dextromethorphan when compounded with one or more other therapeutically active substances—

(a)in divided preparations containing 30 mg or less of dextromethorphan per dosage unit and with a recommended dose not exceeding 30 mg of dextromethorphan; or

(b)in undivided preparations containing 0.3% or less of dextromethorphan with a recommended dose not exceeding 30 mg of dextromethorphan

Dicophane (DDT) in preparations for human therapeutic use

Dicyclomine in preparations containing 0.1% or less of dicyclomine

Dihydrocodeine when compounded with aspirin and no other therapeutically active substance, in divided preparations containing 5 mg or less of dihydrocodeine per dosage unit and with a recommended dose not exceeding 10 mg of dihydrocodeine when—

(a)packed in blister or strip packaging or in a container with a child-resistant closure; and

(b)in a primary pack containing 25 or less dosage units

Dimenhydrinate in primary packs of 10 doses or less, for the prevention or treatment of motion sickness

Dimethisoquin in preparations for topical use

Diphemanil methylsulphate in preparations for topical use

Diphenhydramine—

(a)in primary packs of 10 doses or less, for the prevention or treatment of motion sickness; or

(b)in oral preparations when compounded with one or more of the following medicaments:

(i)an antitussive, except codeine or dihydrocodeine;

(ii)an expectorant;

(iii)a sympathomimetic amine;

except in preparations for the treatment of children under 2 years of age

Diphenylpyraline in oral preparations when compounded with one or more of the following medicaments:

(a)an antitussive, except codeine or dihydrocodeine;

(b)an expectorant;

(c)a sympathomimetic amine;

except in preparations for the treatment of children under 2 years of age

Doxylamine in oral preparations when compounded with one or more of the following medicaments:

(a)an antitussive, except codeine or dihydrocodeine;

(b)an expectorant;

(c)a sympathomimetic amine;

except in preparations for the treatment of children under 2 years of age

Ephedrine for internal use, for the relief of respiratory tract conditions only, when compounded with one or more other therapeutically active substances in preparations containing 30 mg or less of ephedrine per recommended dose, except in liquid preparations containing 10 mg or less of ephedrine per recommended dose

Erythrityl tetranitrate for therapeutic use

Etafedrine

Ether for therapeutic use, except—

(a)when included in Schedule 4; or

(b)in preparations containing 10% or less of ether

Ethoheptazine in preparations containing 1% or less of ethoheptazine

Ethylmorphine, when compounded with one or more other therapeutically active substances—

(a)in divided preparations containing 10 mg or less of ethylmorphine per dosage unit and with a recommended dose not exceeding 15 mg of ethylmorphine; or

(b)in undivided preparations containing 0.25% or less of ethylmorphine and with a recommended dose not exceeding 15 mg of ethylmorphine

Fluoride for human therapeutic use, being—

(a)sodium fluoride in preparations for ingestion containing 2.2 mg or less of sodium fluoride per dosage unit; or

(b)in preparations for topical use, except—

(i)when included in Schedule 3;

(ii)in dentifrices containing 1,000 mg/kg or less of fluoride ion; or

(iii)in other substances containing 15 mg/kg or less of fluoride ion

Gelsemium

Glutaraldehyde for human therapeutic use

Glyceryl trinitrate for therapeutic use, except when included in Schedule 4

Guaiphenesin—

(a)in liquid preparations containing 2% (200 mg/10 ml) or less of guaiphenesin; or

(b)in divided preparations containing 120 mg or less of guaiphenesin per dosage unit

Hexachlorophane in preparations for human skin cleansing purposes containing 3% or less of hexachlorophane, except  in preparations for use on infants as specified in Schedule 4

Homatropine in preparations containing 0.25% or less of homatropine

Human chorionic gonadotrophin or its antibody in pregnancy test kits

Hydroquinone (excluding monobenzone and other alkyl ethers of hydroquinone included in Schedule 4) in preparations for external human therapeutic or cosmetic use containing 2% or less of hydroquinone, except hair preparations containing 1% or less of hydroquinone

8-Hydroxyquinoline and its non-halogenated derivatives for human therapeutic use, except in preparations for external use containing 1% or less of such substances

Hyoscine (excluding hyoscine butylbromide)—

(a)in preparations containing 0.25% or less of hyoscine; or

(b)in transdermal applicators containing 2 mg or less of hyoscine

Hyoscyamine in preparations containing 0.25% or less of hyoscyamine

Hyoscyamus in preparations containing 0.25% or less of the alkaloids of hyoscyamus calculated as hyoscyamine

Iodine—

(a)in preparations for internal human therapeutic use containing 300 mg or more of iodine, except—

(i)when included in Schedule 4; or

(ii)when labelled, in letters not less than 1.5 mm in height—

“CAUTION—TOTAL IODINE INTAKE MAY EXCEED RECOMMENDED LEVEL WHEN TAKING THIS PREPARATION”; and

“WARNING—CONTAINS IODINE—DO NOT TAKE WHEN PREGNANT EXCEPT ON PHYSICIAN’S ADVICE”; or

(b)in preparations for external human therapeutic use containing more than 2.5% of available iodine other than as iodine salts, derivatives or iodophors

Iron compounds for human internal use, except—

(a)when included in Schedule 4;

(b)in divided preparations containing 5 mg or less of iron per dosage unit; or

(c)in liquid oral preparations containing 0.1% or less of iron

Isopropamide in preparations containing 2% or less of isopropamide for dermal use

Isosorbide dinitrate for therapeutic use

Lignocaine when included in—

(a)lozenges, pastilles, tablets or capsules containing 30 mg or less of lignocaine in each;

(b)suppositories or bougies containing 200 mg or less of lignocaine in each; or

(c)preparations for topical use, other than eye drops, containing 10% or less of lignocaine

Lindane in preparations for external human therapeutic use containing 2% or less of lindane

Lobelia—

(a)in divided preparations containing 2.5 mg or less of lobeline per dosage unit; or

(b)in undivided preparations containing 0.05% or less of lobeline;

except in preparations for smoking or burning

Lobeline—

(a)in divided preparations containing 2.5 mg or less of lobeline per dosage unit; or

(b)in undivided preparations containing 0.05% or less of lobeline;

except in preparations for smoking or burning

Luteinising hormone or its antibody in human ovulation test kits

Maldison in preparations for external human therapeutic use containing 2% or less of maldison

Mebendazole for human therapeutic use

Mercuric oxide in ointments for human ocular use

Mercury organic compounds for topical human therapeutic use in preparations containing 0.5% or less of mercury

Methoxamine, except in preparations for external use containing 1% or less of methoxamine

Methoxyphenamine

Methylephedrine

Miconazole for human use in preparations containing 2% or less of miconazole for treatment of fungal infections of the skin

Naphazoline

Naproxen in packs of 12 or less tablets or capsules for treatment of spasmodic dysmenorrhoea

Niclosamide for human therapeutic use

Nitric esters of polyhydric alcohols for therapeutic use, except when separately specified in these Schedules

Noscapine

Oxethazaine in preparations for internal use

Oxymetazoline

Papaverine, except when included in Schedule 4

Paracetamol, except—

(a)when included in Schedule 4;

(b)in individually wrapped powders or sachets of granules each containing 1000 mg or less of paracetamol as the only therapeutically active constituent other than effervescent agents when—

(i)the pack is labelled—

“WARNING—THIS MEDICATION MAY BE DANGEROUS WHEN USED IN LARGE AMOUNTS OR FOR A LONG PERIOD”; or

“CAUTION—THIS PREPARATION IS FOR THE RELIEF OF MINOR AND TEMPORARY AILMENTS AND SHOULD BE USED STRICTLY AS DIRECTED.  PROLONGED USE WITHOUT MEDICAL SUPERVISION COULD BE HARMFUL”; and

(ii)in a primary pack containing not more than 12 such powders or sachets;

unless the pack is labelled for the treatment of children under 7 years of age; or

(c)tablets or capsules each containing 500 mg or less of paracetamol as the only therapeutically active constituent other than effervescent agents when—

(i)the pack is labelled—

“WARNING—THIS MEDICATION MAY BE DANGEROUS WHEN USED IN LARGE AMOUNTS OR FOR A LONG PERIOD”; or

“CAUTION—THIS PREPARATION IS FOR THE RELIEF OF MINOR AND TEMPORARY AILMENTS AND SHOULD BE USED STRICTLY AS DIRECTED.  PROLONGED USE WITHOUT MEDICAL SUPERVISION COULD BE HARMFUL”;

(ii)packed in blister or strip packaging or in containers with a child‑resistant closure; and

(iii)in a primary pack containing not more than 25 such tablets or capsules;

unless the pack is labelled for the treatment of children under 7 years of age

Phedrazine

Phenazone for external use

Pheniramine—

(a)in primary packs of 10 doses or less, for the prevention or treatment of motion sickness; or

(b)in oral preparations when compounded with one or more of the following medicaments:

(i)an antitussive, except codeine or dihydrocodeine;

(ii)an expectorant;

(iii)a sympathomimetic amine;

except in preparations for the treatment of children under 2 years of age

Phenol, or any homologue of phenol boiling below 220oC, for human therapeutic use, except in preparations containing 3% or less of such substances

Phenylenediamines and alkylated phenylenediamines for therapeutic use

Phenylephrine, except—

(a)when included in Schedule 4;

(b)preparations containing 0.5% or less of phenylephrine; or

(c)preparations for external use containing 1% or less of phenylephrine

Pholcodine when compounded with one or more other therapeutically active substances—

(a)in divided preparations containing 10 mg or less of pholcodine per dosage unit and with a recommended dose not exceeding 25 mg of pholcodine; or

(b)in undivided preparations containing 0.5% or less of pholcodine and with a recommended dose not exceeding 25 mg of pholcodine

Podophyllotoxin for external human therapeutic use in preparations containing 2% or less of podophyllotoxin

Podophyllum resin (podophyllin) for external human therapeutic use in preparations containing 10% or less of podophyllin

Potassium chlorate for therapeutic use except in preparations containing 10% or less of potassium chlorate

Pramoxine when included in preparations for external use, other than eye drops, containing 1% or less of pramoxine

Procyclidine in preparations containing 5% or less of procyclidine for dermal use

Promethazine—

(a)in primary packs of 10 doses or less, for the prevention or treatment of motion sickness; or

(b)in oral preparations when compounded with one or more of the following medicaments:

(i)an antitussive, except codeine or dihydrocodeine;

(ii)an expectorant;

(iii)a sympathomimetic amine;

except in preparations for the treatment of children under 2 years of age

Propantheline in preparations for topical use

Pseudoephedrine—

(a)in preparations containing 60 mg or less of pseudoephedrine per recommended dose; or

(b)in slow-release preparations containing 120 mg or less of pseudoephedrine per recommended dose, for which approval for the slow-release characteristic has been granted by the Commonwealth Department of Community Services and Health;

except when included in Schedule 4

Pyrantel for human therapeutic use

Pyrithione zinc for human therapeutic use, except—

(a)in semi-solid hair preparations; or

(b)in shampoos containing 2% or less of pyrithione zinc when labelled—

“KEEP OUT OF EYES”; or

“IF IN EYES, RINSE WELL WITH WATER”

Salicylamide, except when included in Schedule 4

Silver salts for therapeutic use, except—

(a)chewing tablets containing 5 mg or less of silver per tablet when the pack is labelled—

“WARNING—OVERUSE MAY STAIN THE SKIN OR MOUTH”; or

(b)solutions containing 0.3% or less of silver when the pack is labelled—

“WARNING—OVERUSE MAY STAIN THE SKIN OR MOUTH”

Sodium cromoglycate in nasal preparations for topical use

Sodium nitrite for therapeutic use

Staphisagria, except in preparations containing 0.2% or less of staphisagria

Stramonium in preparations containing 0.25% or less of the alkaloids calculated as hyoscyamine, except preparations for smoking or burning

Tetrahydrozoline

Thenyldiamine—

(a)in nasal preparations for topical use; or

(b)in oral preparations when compounded with one or more of the following medicaments:

(i)an antitussive except codeine or dihydrocodeine;

(ii)an expectorant;

(iii)a sympathomimetic amine;

except in preparations for the treatment of children under 2 years of age

Tramazoline

Trimeprazine in oral preparations when compounded with one or more of the following medicaments:

(a)an antitussive except codeine or dihydrocodeine;

(b)an expectorant;

(c)a sympathomimetic amine;

except in preparations for the treatment of children under 2 years of age

Triprolidine in oral preparations when compounded with one or more of the following medicaments:

(a)an antitussive except codeine or dihydrocodeine;

(b)an expectorant;

(c)a sympathomimetic amine;

except in preparations for the treatment of children under 2 years of age

Tymazoline

Xylometazoline

SCHEDULE 3  Section 3

Acepifylline in liquid oral preparations

Adrenaline in preparations containing 1% or less of adrenaline, except in preparations containing 0.02% or less of adrenaline

Aminophylline in liquid oral preparations

Amyl nitrite

Azatadine in oral preparations

Benzoyl peroxide in preparations containing 10% or less of benzoyl peroxide for external human therapeutic use, except when included in Schedule 2

Brompheniramine in oral preparations, except when included in Schedule 2

Buclizine in oral preparations, except when included in Schedule 2

Butyl nitrite

Chlorofluorocarbons alone or in combination with other propellants or refrigerants in liquefied gas form for therapeutic use

Chlorpheniramine in oral preparations, except when included in Schedule 2

Clemastine in oral preparations

Clotrimazole for human use in preparations containing 1% or less of clotrimazole, for treatment of fungal infections of the skin

Codeine when—

(a)compounded with aspirin, paracetamol or any one of their derivatives and no other analgesic substance; and

(b)in divided preparations containing 10 mg or less of codeine per dosage unit with a recommended dose not exceeding 15 mg of codeine;

except when included in Schedule 2

Cyproheptadine in oral preparations

Dexchlorpheniramine in oral preparations, except when included in Schedule 2

Dihydrocodeine when compounded with one or more other therapeutically active substances—

(a)in divided preparations containing 10 mg or less per dosage unit and with a recommended dose not exceeding 15 mg of dihydrocodeine; or

(b)in undivided preparations containing 0.25% or less of dihydrocodeine with a recommended dose not exceeding 15 mg of dihydrocodeine;

except when included in Schedule 2

Dimenhydrinate in oral preparations, except when included in Schedule 2

Dimethindene in oral preparations

Diphenhydramine in oral preparations, except when included in Schedule 2

Diphenylpyraline in oral preparations, except when included in Schedule 2

Dithranol for human therapeutic use

Doxylamine in oral preparations, except when included in Schedule 2

Econazole for human use in preparations containing 1% or less of econazole for treatment of fungal infections of the skin

Ephedrine for internal use, for the relief of respiratory tract conditions only, when compounded with one or more other therapeutically active substances, except—

(a)when included in Schedule 2; or

(b)in liquid preparations containing 10 mg or less of ephedrine per recommended dose

Fenoterol in metered aerosols delivering 200 micrograms or less of fenoterol per metered dose

Flavoxate

Fluorides in dentifrices containing more than 1000 mg/kg of fluoride ion

Fluorocarbons alone or in combination with other propellants or refrigerants in liquefied gas form for therapeutic use

Folic acid for human therapeutic use, except in preparations containing 500 micrograms or less of folic acid per recommended daily dose

Folinic acid for human therapeutic use, except in preparations containing 500 micrograms or less of folinic acid per recommended daily dose

Hydrocortisone (excluding its salts and derivatives other than hydrocortisone acetate) as the only therapeutically active substance in preparations for dermal use containing 0.5% or less of hydrocortisone in packs containing 30 grams or less where the labelling warns against—

(a)contact with the eyes; or

(b)use for acne;

and against use, except on medical advice—

(c)on children under 2 years of age;

(d)for more than 7 days; or

(e)under occlusive dressings

Ibuprofen as the only therapeutically active substance in divided preparations for oral use containing 200 mg or less of ibuprofen per dosage unit in a pack containing 50 or less dosage units and with a recommended daily dose not exceeding 1200 mg of ibuprofen

Idoxuridine in preparations containing 0.5% or less of idoxuridine for dermal use

Insulin

Isoconazole for human use in preparations containing 1% or less of isoconazole, for treatment of fungal infections of the skin

Loperamide in packs of 8 dosage units or less, each dosage unit containing 2 mg or less of loperamide

Mefenamic acid in packs of 30 or less capsules for treatment of spasmodic dysmenorrhoea

Mepyramine in oral preparations

Methdilazine in oral preparations

Miconazole for human use in topical preparations containing 2% or less of miconazole for the treatment of oral candidiasis

Nicotine in chewing tablets containing 2 mg or less of nicotine per tablet for use as an aid in withdrawal from tobacco smoking

Nitrofurazone in preparations for dermal use containing 0.2% or less of nitrofurazone

Nystatin in preparations for topical use for treatment of candidal infections only

Octyl nitrite

Pheniramine in oral preparations, except when included in Schedule 2

Phenylpropanolamine in preparations containing 25 mg or less per recommended dose of phenylpropanolamine when labelled only for the relief of coughs or colds

Phenyltoloxamine in oral preparations

Podophyllotoxin for external human therapeutic use in preparations containing 4% or less of podophyllotoxin, except when included in Schedule 2

Podophyllum resin (podophyllin) for external human therapeutic use in preparations containing 20% or less of podophyllin, except when included in Schedule 2

Promethazine in oral preparations, except when included in Schedule 2

Pseudoephedrine, except when included in Schedule 2 or 4

Quinine for human internal therapeutic use, except in liquids containing 40 mg/litre or less of quinine

Salbutamol—

(a)in metered aerosols delivering 100 micrograms or less of salbutamol per metered dose; or

(b)in capsules of dry powder for inhalation delivering 200 micrograms or less of salbutamol per dose

Santonin

Terbutaline in metered aerosols delivering 250 micrograms or less of terbutaline per metered dose

Terfenadine as the only therapeutically active substance in divided preparations for oral use containing 60 mg or less of terfenadine per dosage unit in a pack containing 20 or less dosage units

Thenyldiamine in oral preparations, except when included in Schedule 2

Theophylline in liquid oral preparations

Tioconazole for human use in preparations containing 1% or less of tioconazole for treatment of fungal infections of the skin

Tretinoin for external human therapeutic use

Trimeprazine—

(a)in solid oral preparations; or

(b)in liquid oral preparations containing 10 mg or less of trimeprazine per 5 ml;

except when included in Schedule 2

Triprolidine in oral preparations, except when included in Schedule 2

SCHEDULE 4  Section 3

Acebutolol

Acepifylline, except when included in Schedule 3

Acepromazine

Acetanilide and alkyl acetanilides, for human therapeutic use

Acetazolamide

Acetohexamide

Acetylcholine

Acetylcysteine

Acetyldihydrocodeine when compounded with one or more other medicaments—

(a)in divided preparations containing not more than 100 mg of acetyldihydrocodeine per dosage unit; or

(b)in undivided preparations with a concentration of not more than 2.5% of acetyldihydrocodeine

Acetylmethyldimethyloximidophenylhydrazine

Actinomycin D (dactinomycin)

Acyclovir

Adiphenine

Adrenaline, except—

(a)when included in Schedule 3; or

(b)in preparations containing 0.02% or less of adrenaline

Alclometasone

Alcuronium salts

Allopurinol

Allyloestrenol

Alphadolone

Alphaxalone

Alprazolam

Alprenolol

Alprostadil

Amantadine

Ambenonium

Ambucetamide

Ambutonium

Amethocaine

Amikacin

Amiloride

3-Aminobenzoic acid ethyl ester methanesulphonate

Aminocaproic acid

Aminoglutethimide

Aminometradine

Aminophenazone and its derivatives, for the treatment of animals

Aminophylline, except when included in Schedule 3

Aminopterin

4-Aminopyridine

Aminorex

Aminosalicylic acid

Amiodarone

Amiphenazole

Amisometradine

Amitriptyline

Amodiaquine

Amoxycillin

Amphomycin

Amphotericin

Ampicillin

Amsacrine

Amylobarbitone when packed and labelled for injection

Amylocaine

Anabolic steroidal agents, except when separately specified in these Schedules

Angiotensin amide

Antazoline, except when included in Schedule 2

Antibiotics, except—

(a)when separately specified in these Schedules; or

(b)nisin

Antigens for human therapeutic use

Antihistamines, except—

(a)when included in Schedule 2 or 3; or

(b)when separately specified in this Schedule

Antimony organic compounds for therapeutic use

Apomorphine

Aprotinin

Arsenic—see Thiacetarsamide

Aspirin—

(a)when combined with caffeine, paracetamol or salicylamide or any derivative of these substances; or

(b)for injection

Astemizole

Atenolol

Atracurium besylate

Atropine, except when included in Schedule 2

Auranofin

Avoparcin, except when packed and labelled for use as an animal feed additive

Azaperone

Azapetine

Azatadine, except when included in Schedule 3

Azlocillin

Aztreonam

Bacampicillin

Bacitracin, except—

(a)when included in Schedule 6;

(b)in animal feeds for growth promotion containing 50 mg/kg or less of antibiotic substances; or

(c)in milk replacers for calves and starter rations for pigs containing 100 mg/kg or less of antibiotic substances

Baclofen

Bamipine

Barbiturates, except when separately specified in these Schedules

Beclamide

Belladonna, except when included in Schedule 2

Bemegride

Benactyzine and other substances structurally derived from diphenylmethane with ataractic properties when used for therapeutic purposes

Bendrofluazide

Benorylate

Benserazide

Benzamine, except when included in Schedule 2

Benzhexol

Benzilonium

Benzocaine, except when included in Schedule 2

Benzodiazepine derivatives, except when separately specified in these Schedules

Benzoyl peroxide in preparations for external human therapeutic use, except when included in Schedule 2 or 3

Benzphetamine

Benztropine

Benzydamine, except when included in Schedule 2

Benzylpenicillin (including procaine penicillin), except when included in Schedule 6

Betahistine

Bethanechol chloride

Bethanidine

Bifonazole

Biperiden

Bismuth compounds for human therapeutic or cosmetic use, except—

(a)bismuth citrate when incorporated in hair colourant preparations in concentrations of 0.5% or less;

(b)bismuth oxychloride in cosmetics; or

(c)bismuth formic iodide or bismuth subiodide in dusting powders containing 3% or less of bismuth

Bleomycin

Boron for human therapeutic use—

(a)for internal use

(b)in glycerines or honeys of borax or boric acid;

(c)in dusting powders for paediatric use; or

(d)as a therapeutically active ingredient in other preparations for dermal use except—

(i)in antifungal preparations; or

(ii)in preparations containing 0.1% or less of boron

Bretylium

Bromazepam

Bromides, inorganic, for therapeutic use

Bromocriptine

Bromoform for therapeutic use

Brompheniramine, except when included in Schedule 2 or 3

Bromvaletone

Buclizine, except when included in Schedule 2 or 3

Bufexamac, except—

(a)in preparations for dermal use containing 5% or less of bufexamac; or

(b)in suppositories

Bumetanide

Bupivacaine

Buprenorphine

Buspirone

Busulphan

Butacaine

Butylaminobenzoate, except when included in Schedule 2

Butylchloral hydrate

Calcitonin

Calcitriol

Calcium carbimide for therapeutic use

Camphorated oil excluding admixtures

Camphotamide

Candicidin

Canine tick anti-serum

Cantharidin

Capreomycin

Captodiame

Captopril

Capuride

Caramiphen

Carbachol

Carbamazepine

Carbaryl for human therapeutic use, except when included in Schedule 2

Carbazochrome

Carbenicillin

Carbenoxolone, except when included in Schedule 2

Carbidopa

Carbimazole

Carbocromen

Carboplatin

Carbromal

Cardiac glycosides, except when separately specified in these Schedules

Carindacillin

Carmustine

Carnidazole for the treatment of pigeons

Catalin

Cathine

Cefaclor

Cefoperazone

Cefotaxime

Cefotetan

Cefoxitin

Ceftazidime

Ceftriaxone

Cephacetrile

Cephadroxil for the treatment of animals

Cephalexin

Cephaloridine

Cephalothin

Cephamandole

Cephapirin

Cephazolin

Cephradine

Chenodeoxycholic acid

Chloral formamide

Chloral hydrate, except in preparations for topical use containing 2% or less of chloral hydrate

a-Chloralose—see Chloralose

Chloralose, except when included in Schedule 6

Chlorambucil

Chloramphenicol

Chlorazanil

Chlorbutol in preparations for human oral use, except in preparations containing 0.5% or less of chlorbutol as a preservative

Chlorcyclizine

Chlordiazepoxide

Chlormerodrin

Chlormethiazole

Chlormezanone

Chloroform for use in anaesthesia

2-(4-Chlorophenyl)-1,2,4-triazole [5,1a]-isoquinoline for the treatment of animals

Chloroquine

Chlorothiazide

Chlorpheniramine, except when included in Schedule 2 or 3

Chlorphentermine

Chlorpromazine

Chlorpropamide

Chlorprothixene

Chlortetracycline, except when included in Schedule 6

Chlorthalidone

Chlorzoxazone

Cholestyramine for human therapeutic use

Chymopapain, injection for human therapeutic use

Ciclacillin

Cilastatin

Cimetidine

Cinchocaine

Cinoxacin

Ciprofloxacin

Cisapride

Cisplatin

Clanobutin for the treatment of animals

Clavulanic acid

Clemastine, except when included in Schedule 3

Clemizole

Clenbuterol for the treatment of animals

Clidinium

Clindamycin

Clobazam

Clobetasone-17-butyrate

Clofenamide

Clofibrate

Clomiphene

Clomipramine

Clomocycline

Clonazepam

Clonidine

Clopamide

Cloprostenol for the treatment of animals

Clorazepate

Clorexolone

Clorprenaline

Clotrimazole, except when included in Schedule 3 or 6

Cloxacillin

Clozapine

Codeine when compounded with one or more other therapeutically active substances—

(a)in divided preparations containing 30 mg or less of codeine per dosage unit; or

(b)in undivided preparations containing 1% or less of codeine;

except when included in Schedule 2 or 3

Colaspase

Colchicine

Colestipol for human therapeutic use

Colistin

Cortisone and steroid suprarenal cortical hormones, except hydrocortisone in Schedule 3

Crystal violet for human therapeutic use

Curare

Cyclandelate

Cyclizine

Cyclofenil

Cyclopenthiazide

Cyclopentolate

Cyclophosphamide

Cyclopropane for therapeutic use

Cycloserine

Cyclosporin

Cyclothiazide

Cycrimine

Cyproheptadine, except when included in Schedule 3

Cyproterone

Cytarabine

Dacarbazine

Danazol

Dantrolene

Dapsone

Daunorubicin

Deanol

Debrisoquine

Demecarium bromide

Demeclocycline

Desipramine

Desmopressin (DDAVP)

Detomidine for the treatment of animals

Dexchlorpheniramine, except when included in Schedule 2 or 3

Dexfenfluramine

Dextromethorphan, except when included in Schedule 2

Dextropropoxyphene—

(a)in divided preparations containing 135 mg or less of dextropropoxyphene per dosage unit; or

(b)in liquid preparations containing 2.5% or less of dextropropoxyphene

Dextrorphan

Diazepam

Diazoxide

Dibenzepin

trans-4-((3,5-Dibromo-2-hydroxybenzyl)-amino) cyclohexanol hydrochloride monohydrate (sputolysin), except when included in Schedule 6

Dichloralphenazone

Dichlorphenamide

Diclofenac

Dicyclomine, except when included in Schedule 2

Dienoestrol

Diethazine

Diethylcarbamazine for human therapeutic use

Diethylpropion

Difenoxin in preparations containing, per dosage unit, 0.5 mg or less of difenoxin and a quantity of atropine sulphate equivalent to at least 5% of the dose of difenoxin

Diflunisal

Digitalis and its glycosides

Digoxin antibody

Dihydralazine

Dihydrocodeine when compounded with one or more other medicaments—

(a)in divided preparations containing not more than 100 mg of dihydrocodeine per dosage unit; or

(b)in undivided preparations with a concentration of not more than 2.5% of dihydrocodeine;

except when included in Schedule 2 or 3

Dihydrostreptomycin, except when included in Schedule 6

Diisopropylamine dichloroacetate

Diltiazem

Dimenhydrinate, except when included in Schedule 2 or 3

Dimethindene, except when included in Schedule 3

Dimethisoquin, except when included in Schedule 2

Dimethoxanate

Dimethyl sulphoxide for therapeutic use, except—

(a)when included in Schedule 6; or

(b)in in vitro test kits

Dimetridazole

2,4-Dinitrochlorobenzene for therapeutic use

Dinitrocresols for therapeutic use

Dinitronaphthols for therapeutic use

Dinitrophenols for therapeutic use

Dinitrothymols for therapeutic use

Dinoprost

Diperodon

Diphemanil methylsulphate, except when included in Schedule 2

Diphenhydramine, except when included in Schedule 2 or 3

Diphenidol

Diphenoxylate in preparations containing, per dosage unit, 2.5 mg or less of diphenoxylate and a quantity of atropine sulphate equivalent to at least 1% of the dose of diphenoxylate

Diphenylpyraline, except when included in Schedule 2 or 3

Dipivefrin

Dipyridamole

Disophenol

Disopyramide

Distigmine

Disulfiram for therapeutic use

Dithiazanine, except when included in Schedule 6

Dobutamine

Domperidone

Dopamine

Dothiepin

Doxapram

Doxepin

Doxorubicin

Doxycycline

Doxylamine, except when included in Schedule 2 or 3

Droperidol

Drostanolone

Dydrogesterone

Econazole, except when included in Schedule 3 or 6

Edetic acid for human therapeutic use in preparations for injection or infusion

Emetine, except in preparations containing 0.2% or less of emetine

Enalapril

Enflurane for therapeutic use

Ephedrine, except—

(a)when included in Schedule 2 or 3;

(b)in preparations for topical use containing 1% or less of ephedrine; or

(c)for internal use for the relief of respiratory tract conditions only, when compounded with one or more other therapeutically active substances in liquid preparations containing 10 mg or less of ephedrine per recommended dose

Epicillin

Epirubicin

Ergometrine

Ergot

Erythromycin, except—

(a)when included in Schedule 6;

(b)in animal feeds for growth promotion containing 50 mg/kg or less of antibiotic substances; or

(c)in milk replacers for calves and starter rations for pigs containing 100 mg/kg or less of antibiotic substances

Estramustine

Ethacrynic acid

Ethambutol

Ethamivan

Ethchlorvynol

Ether for use in anaesthesia

Ethinamate

Ethinyloestradiol

Ethoglucid

Ethoheptazine, except when included in Schedule 2

Ethopropazine

Ethosuximide

Ethotoin

Ethoxzolamide

Ethyl chloride for inhalation anaesthesia

Ethylmorphine when compounded with one or more other medicaments—

(a)in divided preparations containing not more than 100 mg of ethylmorphine per dosage unit; or

(b)in undivided preparations with a concentration of not more than 2.5% of ethylmorphine;

except when included in Schedule 2

Ethyloestrenol

Ethynodiol

Etidocaine

Etidronate, except in tooth pastes and gels containing 1% or less of etidronate

Etilefrin hydrochloride

Etoposide

Etretinate

Famotidine

Felodipine

Felypressin

Fencamfamin

Fenfluramine

Fenoprofen

Fenoterol, except when included in Schedule 3

Fenpipramide

Fenpiprane

Fenproporex

Fenprostalene for the treatment of animals

Flavophospholipol, except—

(a)when included in Schedule 6; or

(b)in animal feeds for growth promotion containing 50 mg/kg or less of antibiotic substances

Flecainide

Flucloxacillin

Flucytosine

Flufenamic acid

Flumazanil

Flunisolide

Flunitrazepam

Flunixin meglumine for the treatment of animals

Fluorides in preparations for human ingestion, except when included in Schedule 2 or 3

Fluorouracil

Fluoxetine

Fluoxymesterone

Fluphenazine

Fluprostenol for the treatment of animals

Flurazepam

Fluroxene for inhalation anaesthesia

Fluspirilene

Follicle-stimulating hormone (animal)

Fosfestrol

Framycetin

Frusemide

Fusidic acid

Galanthamine

Gallamine

Gemeprost

Gentamicin

Glibenclamide

Glibornuride

Gliclazide

Glipizide

Glucagon

Glutethimide

Glyceryl trinintrate in preparations for injection

Glycopyrrolate

Glymidine

Gonadorelin

Gonadotrophins, except when separately specified in this Schedule or in Schedule 2

Goserelin acetate

Gramicidin

Griseofulvin

Growth hormone

Guaiphenesin, except when included in Schedule 2

Guanabenz

Guanacline

Guanethidine

Halcinonide

Haloperidol and other substances structurally derived from butyrophenone with ataractic properties, when used for therapeutic purposes, except when separately specified in this Schedule

Halothane for therapeutic use

Heparin for internal therapeutic use

Hetacillin

Hexachlorophane—

(a)in preparations for use on infants; or

(b)in other preparations, except when included in Schedule 2 or 6

Hexamethonium

Hexocyclium

Homatropine, except when included in Schedule 2

Hyaluronic acid in preparations for injection

Hydralazine

Hydrochlorothiazide

Hydrocyanic acid for therapeutic use

Hydroflumethiazide

Hydroquinone (other than its alkyl ethers separately specified in this Schedule) in preparations for human therapeutic or cosmetic use, except—

(a)when included in Schedule 2; or

(b)in hair preparations containing 1% or less of hydroquinone

Hydroxychloroquine

Hydroxyephedrine

Hydroxyprogesterone

Hydroxyurea

Hydroxyzine

Hygromycin, except—

(a)when included in Schedule 6; or

(b)in preparations in concentrations of 50 mg/kg or less of antibiotic substances

Hyoscine, except when included in Schedule 2

Hyoscyamine, except when included in Schedule 2

Hyoscyamus, except when included in Schedule 2

Hypothalamic releasing factors, except when separately specified in this Schedule

Ibufenac

Ibuprofen, except when included in Schedule 3

Idoxuridine, except when included in Schedule 3

Imipenem

Imipramine

Indapamide

Indomethacin

Inositol nicotinate for internal use

Interferon

Ion-exchange resins, anionic and cationic, for internal use in humans, except when separately specified in this Schedule

Iopamidol

Ipratropium

Iproniazid

Iron compounds in injectable preparations for human therapeutic use

Isoaminile

Isocarboxazid

Isoconazole, except when included in Schedule 3 or 6

Isoetharine

Isoflurane for therapeutic use

Isometheptene

Isoniazid

Isoprenaline

Isopropamide, except when included in Schedule 2

Isotretinoin

Isoxuprine

Ivermectin for the treatment of dogs

Kanamycin

Ketamine

Ketoconazole

Ketoprofen

Khellin

Kitasamycin, except—

(a)when included in Schedule 6; or

(b)in animal feeds for growth promotion containing 100 mg/kg or less of antibiotic substances

Labetalol

Latamoxef

Laudexium methylsulphate

Lead compounds for human therapeutic use

Lefetamine

Leptazol

Leuprorelin

Levallorphan

Levamisole—

(a)for human therapeutic use; or

(b)in preparations for the prevention or treatment of heartworm in dogs

Levodopa

Levonorgestrel

Lidoflazine

Lignocaine, except when included in Schedule 2

Lincomycin

Lindane for human therapeutic use, except when included in Schedule 2

Liothyronine sodium (triiodothyronine)

Lithium salts for therapeutic use, except in preparations containing 0.01% or less of lithium

Lobelia, except—

(a)when included in Schedule 2; or

(b)in preparations for smoking or burning

Lobeline, except—

(a)when included in Schedule 2; or

(b)in preparations for smoking or burning

Lomustine

Loperamide, except when included in Schedule 3

Lorazepam

Loxapine

Luteinising hormone—see also Gonadotrophins

Lymecycline

Mafenide, except when included in Schedule 6

Maldison for human therapeutic use, except when included in Schedule 2

Maprotiline

Mazindol

Mebeverine

Mebhydrolin

Mecamylamine

Meclofenoxate

Meclozine

Medazepam

Medroxyprogesterone

Mefenamic acid, except when included in Schedule 3

Mefenorex

Mefloquine

Mefruside

Megestrol

Melphalan

Mepacrine

Mepenzolate

Mephenesin

Mephentermine

Mepivacaine

Meprobamate

Mepyramine, except when included in Schedule 3

Mercaptopurine

Mercury for therapeutic use, except when included in Schedule 2 or 6

Mesalazine

Mesterolone

Mestranol

Metaraminol

Metergoline for the treatment of animals

Metformin

Methacycline

Methandienone

Methandriol

Methanthelinium

Methazolamide

Methdilazine, except when included in Schedule 3

Methenolone

Methicillin

Methimazole

Methixene

Methocarbamol

Methotrexate

Methoxsalen

Methoxyflurane for therapeutic use

Methsuximide

Methyclothiazide

Methylandrostanolone

Methyldopa

Methylpentynol and other substituted alkynes for internal use

Methyltestosterone

Methyprylone

Methysergide

Metoclopramide

Metolazone

Metoprolol

Metrizamide

Metronidazole including benzoyl metronidazole

Metyrapone

Mexiletine

Mezlocillin

Mianserin

Mibolerone

Miconazole, except when included in Schedule 2, 3 or 6

Midazolam

Minocycline

Minoxidil

Misoprostol

Mithramycin

Mitobronitol

Mitomycin

Mitozantrone

Monensin, except—

(a)when included in Schedule 6; or

(b)in animal feeds containing 33 mg/kg or less of antibiotic substances

Monobenzone and other alkyl ethers of hydroquinone for human therapeutic use or cosmetic use

Monoclonal antibodies for therapeutic use, except in diagnostic test kits

Moperone

Mupirocin

Mustine

Nadolol

Nalbuphine

Nalidixic acid, except when included in Schedule 6

Nalorphine

Naloxone

Nandrolone

Naproxen, except when included in Schedule 2

Narasin, except—

(a)when included in Schedule 6; or

(b)in animal feeds containing 100 mg/kg or less of antibiotic substances

Natamycin

Neomycin, except when included in Schedule 6

Neostigmine

Netilmicin

Nicocodine when compounded with one or more other medicaments—

(a)in divided preparations containing not more than 100 mg of nicocodine per dosage unit; or

(b)in undivided preparations with a concentration of not more than 2.5% of nicocodine

Nicodicodine when compounded with one or more other medicaments—

(a)in divided preparations containing not more than 100 mg of nicodicodine per dosage unit; or

(b)in undivided preparations with a concentration of not more than 2.5% of nicodicodine

Nicotine in chewing tablets containing 4 mg or less of nicotine per tablet for use as an aid in withdrawal from tobacco smoking, except when included in Schedule 3

Nicotinic acid for human therapeutic use, except—

(a)in preparations containing 50 mg or less of nicotinic acid per recommended daily dose; or

(b)nicotinamide

Nicotinyl alchohol for internal use

Nicoumalone for internal therapeutic use

Nifedipine

Nifenazone

Nikethamide

Niridazole

Nitrazepam

Nitrofuran and its derivatives for human therapeutic use, except when included in Schedule 3

Nitrous oxide for therapeutic use

Nizatadine

Nomifensine

Noradrenaline, excluding its derivatives

Norcodeine when compounded with one or more other medicaments—

(a)in divided preparations containing not more than 100 mg of norcodeine per dosage unit; or

(b)in undivided preparations with a concentration of not more than 2.5% of norcodeine

Norethandrolone

Norethisterone

Norfloxacin

Nortriptyline

Novobiocin, except when included in Schedule 6

Nystatin, except when included in Schedule 3

Octamylamine

Octatropine

Octreotide

Oestradiol, except when included in Schedule 6

Oestriol

Oestrone

Oleandomycin, except—

(a)when included in Schedule 6; or

(b)in animal feeds for growth promotion containing 50 mg/kg or less of antibiotic substances

Olsalasine sodium

Omeprazole

Opipramol

Orciprenaline

Organophosphorus compounds with anticholinesterase activity for human therapeutic use, except—

(a)when included in Schedule 2; or

(b)when separately specified in this Schedule

Ornidazole

Ornipressin

Orphenadrine

Orthocaine

Orthopterin

Oxacillin

Oxandrolone

Oxazepam

Oxiconazole

Oxolamine

Oxpentifylline

Oxprenolol

Oxybuprocaine

Oxymesterone

Oxymetholone

Oxyphenbutazone

Oxyphencyclimine

Oxyphenonium

Oxytetracycline, except when included in Schedule 6

Oxytocin

Pamaquine

Pancuronium bromide

Papaverine for injection

Paracetamol when combined with aspirin, caffeine or salicylamide or any derivative of these substances

Paraldehyde

Paromomycin

Pemoline

Pempidine

Penicillamine

Pentamethonium

Penthienate

Pentobarbitone when packed and labelled for injection

Pentolinium

Perhexilene

Pericyazine

Perphenazine

Phenacemide

Phenacetin for therapeutic use

Phenazone, except when included in Schedule 2

Phenazopyridine

Phenelzine

Phenethicillin, except when included in Schedule 6

Phenformin

Phenglutarimide

Phenindione for internal therapeutic use

Pheniramine, except when included in Schedule 2 or 3

Phenoxybenzamine

Phenoxymethylpenicillin, except when included in Schedule 6

Phensuximide

Phentermine

Phenthimentonium

Phentolamine

Phenyapin

Phenylbutazone

Phenylephrine in preparations for human ophthalmic use containing 5% or more of phenylephrine

Phenylpropanolamine, except when included in Schedule 3

Phenyltoloxamine, except when included in Schedule 3

Phenytoin

Pholcodine when compounded with one or more other medicaments—

(a)in divided preparations containing not more than 100 mg of pholcodine per dosage unit; or

(b)in undivided preparations with a concentration of not more than 2.5% of pholcodine;

except when included in Schedule 2

Physostigmine

Picrotoxin

Pilocarpine, except in preparations containing 0.025% or less of pilocarpine

Pimozide

Pindolol

Pipenzolate

Piperacillin

Piperidolate

Pipobroman

Pipradrol

Pirenzepine

Piroxicam

Pituitary and its extracts and active principles or their synthetic substitutes, except when separately specified in this Schedule

Pizotifen

Podophyllotoxin for human therapeutic use, except when included in Schedule 2 or 3

Podophyllum resin (podophyllin) for human therapeutic use, except when included in Schedule 2 or 3

Polyestradiol

Polymethylene bistrimethyl ammonium compounds

Polymyxin

Polysulphated glycosaminoglycans in preparations for injection, except where otherwise specified in this Schedule

Potassium perchlorate for therapeutic use

Practolol

Pramoxine, except when included in Schedule 2

Prazepam

Praziquantel for human therapeutic use

Prazosin

Pregnenolone acetate, except in preparations for topical use

Prenylamine

Prilocaine

Primaquine

Primidone

Probenecid

Probucol

Procainamide

Procaine

Procarbazine

Prochlorperazine

Procyclidine, except when included in Schedule 2

Progesterone, except when included in Schedule 6

Proguanil

Prolintane

Promazine

Promethazine, except when included in Schedule 2 or 3

Propanidid

Propantheline, except when included in Schedule 2

Propofol

Propoxur for human therapeutic use

Propranolol

Propylhexedrine

Propylthiouracil

Propyphenazone

Proquazone

Prostaglandins, except where separately specified in this Schedule

Prostianol for the treatment of animals

Prothionamide

Protirelin (thyrotrophin releasing factor)

Protriptyline

Proxymetacaine

Pseudoephedrine in preparations for stimulant, appetite suppression or weight control purposes

Pyrazinamide

Pyridostigmine

Pyridoxine hydrochloride in preparations for human use containing more than 50 mg of pyridoxine per recommended daily dose, unless labelled—

“WARNING—THIS MEDICATION MAY BE DANGEROUS WHEN USED IN LARGE AMOUNTS OR FOR A LONG TIME”; or

“WARNING—THIS PRODUCT CONTAINS PYRIDOXINE HYDROCHLORIDE WHICH MAY BE DANGEROUS WHEN USED IN LARGE AMOUNTS OR FOR A LONG TIME”

Pyrimethamine

Pyrovalerone

Quinethazone

Quinidine

Ranitidine

Rauwolfia serpentina

Ribavirin

Rifampicin

Rimiterol hydrobromide

Ritodrine

Rolitetracycline

Rosoxacin

Salbutamol, except when included in Schedule 3

Salicylamide when combined with aspirin, caffeine or paracetamol or any derivative of these substances

Salinomycin, except—

(a)when included in Schedule 6; or

(b)in animal feeds containing 60 mg/kg or less of antibiotic substances

Selenium for therapeutic use, except—

(a)when included in Schedule 5 or 6;

(b)as elemental selenium in pellets containing 50 mg/kg or less of selenium for the treatment of animals;

(c)in tablets, for the treatment of animals, each—

(i)weighing 2 g or more; and

(ii)containing 30 micrograms or less of selenium; or

(d)in animal feeds containing 0.1 g/tonne or less of selenium

Semisodium valproate

Sera for human therapeutic use

Sermorelin

Sex hormones and all substances having sex hormonal activity, except when separately specified in these Schedules

Silver sulphadiazine

Sisomycin

Sodium cellulose phosphate for human internal use

Sodium cromoglycate, except when included in Schedule 2

Sodium nitroprusside for human therapeutic use

Sodium pentosan polysulphate for the treatment of animals

Sodium valproate

Sontoquine

Sotalol

Sparteine

Spectinomycin

Spiramycin, except—

(a)when included in Schedule 6; or

(b)in animal feeds for growth promotion in pigs or poultry containing 50 mg/kg or less of antibiotic substances

Spironolactone

Sputolysin—see trans-4-((3,5-Dibromo-2-hydroxybenzyl)-amino) cyclohexanol hydrochloride monohydrate

Stanolone

Stanozolol

Stilboestrol

Stramonium, except—

(a)when included in Schedule 2; or

(b)in preparations for smoking or burning

Streptomycin, except when included in Schedule 6

Strophanthus and its glycosides

Strychnine in preparations containing 1.5% or less of strychnine for the treatment of animals

Sulfadoxine

Sulphametrole

Sulindac

Sulphatroxazole for the treatment of animals

Sulphinpyrazone

Sulphomyxin

Sulphonal and alkyl sulphonals

Sulphonamides, except—

(a)when included in Schedule 6;

(b)when separately specified in this Schedule;

(c)oryzalin;

(d)sulphaquinoxaline in animal feeds containing 200 mg/kg or less of sulphaquinoxaline; or

(e)sulphaquinoxaline when incorporated in baits for the destruction of vermin

Sulthiame

Suxamethonium salts

Tacrine

Tamoxifen

Temazepam

Teniposide

Tenoxicam

Terbutaline, except when included in Schedule 3

Terfenadine, except when included in Schedule 3

Teropterin

Testosterone, except when included in Schedule 6

Tetrabenazine

Tetracosactrin

Tetracycline, except when included in Schedule 6

Thalidomide

Thenyldiamine, except when included in Schedule 2 or 3

Theophylline, except when included in Schedule 3

Thiacetarsamide in preparations for the prevention or treatment of heart worm in dogs

Thiacetazone

Thiambutosine

Thiazosulphone

Thiethylperazine

Thioguanine

Thiopropazate

Thioridazine

Thiotepa

Thiothixene

Thiouracil

Thiourea for therapeutic use

Thyroid and its extracts and active principles, except when separately specified in this Schedule

Thyrotrophin (TSH)

Thyroxine sodium

Tiamulin, except—

(a)when included in Schedule 6; or

(b)in prepared animal feeds

Ticarcillin

Tiemonium

Tigloidine

Tiletamine for the treatment of animals

Timolol

Tinidazole

Tioconazole, except when included in Schedule 3

Tipepidine

Tobramycin

Tocainide

Tolazamide

Tolazoline for internal use

Tolbutamide

Tolpropamine

Toxoids for human therapeutic use

Tranexamic acid

Tranylcypromine

Tretamine

Triamterene

Triaziquone

Triazolam

Trichloroethylene for therapeutic use

Triclofos

Tricyclamol

Tridihexethyl

Trifluoperazine

Trifluperidol

Trimeprazine, except when included in Schedule 2 or 3

Trimetaphan

Trimethoprim

Trimipramine

Trimustine

Trioxysalen

Tripelennamine

Triprolidine, except when included in Schedule 2 or 3

Tropicamide

Troxidone

Tubocurarine

Tulobuterol

Tylosin, except—

(a)when included in Schedule 6;

(b)in animal feeds for growth promotion containing 50 mg/kg or less of antibiotic substances; or

(c)in milk replacers for calves or starter rations for pigs containing 100 mg/kg or less of antibiotic substances

Urethane, excluding its derivatives, for therapeutic use

Urofollitrophin (human follicle-stimulating hormone)

Vaccines for human therapeutic use

Vaccines, veterinary live virus, except—

(a)poultry vaccines;

(b)pigeon pox vaccine; or

(c)scabby mouth vaccine

Valnoctamide

Vancomycin

Vasopressin

Vecuronium bromide

Verapamil

Veratrum

Vidarabine

Vinblastine

Vincristine

Vindesine

Viprynium

Virginiamycin, except—

(a)when included in Schedule 6; or

(b)in animal feeds for growth promotion containing 50 mg/kg or less of antibiotic substances

Visnadine

Vitamin A for human therapeutic use, except in preparations containing 10 000 I.U. or less of vitamin A per recommended daily dosage

Vitamin D for human therapeutic use, except in preparations containing 25 micrograms or less of vitamin D per recommended daily dosage

Warfarin for internal therapeutic use

Xanthinol nicotinate

Xylazine

Yohimbine

Zeranol, except when included in Schedule 6

Zidovudine

Zinc compounds for human internal use, except—

(a)in preparations with a recommended daily dose of 25 mg or less of zinc; or

(b)in preparations with a recommended daily dose of more than 25 mg but not more than 50 mg of zinc when the pack is labelled—

“WARNING—MAY BE DANGEROUS IF TAKEN IN LARGE AMOUNTS OR FOR A LONG PERIOD”; or

“WARNING—CONTAINS ZINC, WHICH MAY BE DANGEROUS IF TAKEN IN LARGE AMOUNTS OR FOR A LONG PERIOD”

Zolazepam for the treatment of animals

SCHEDULE 5  Section 3

Acetic acid (excluding its salts and derivatives) in preparations containing more than 30% of acetic acid, except—

(a)when included in Schedule 2 or 6; or

(b)for therapeutic use

Acetone, except—

(a)in preparations containing 25% or less of acetone; or

(b)in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of acetone

Acetophenone—see Phenyl methyl ketone

Aklomide

Alkaline salts, being the carbonate, orthosilicate, metasilicate or tribasic phosphate salts of sodium or potassium, in any combination, except—

(a)in preparations containing 10% or less of combined substances;

(b)in solid preparations whose pH in 10 g/L aqueous solution is 11.5 or less; or

(c)in liquid preparations having a pH of 11.5 or less

Alloxydim

Ametryn

Amines for use as curing agents for epoxy resins, except when separately specified in these Schedules

Amitrole

Ammonia (exluding its salts and derivatives other than ammonium hydroxide) in preparations containing 5% or less of ammonia, except—

(a)in preparations for human internal therapeutic use;

(b)in preparations for inhalation when absorbed in an inert solid material; or

(c)in preparations containing 0.5% or less of ammonia

Ammonium thiocyanate, except in preparations containing 10% or less of ammonium thiocyanate

Anhydrides, organic, for use as curing agents for epoxy resins, except when separately specified in these Schedules

Arsenic organic compounds in herbicides or defoliant preparations containing 3% or less of arsenic, except when separately specified in this Schedule

Azamethiphos

Barium silicofluoride when coated on paper in an amount not exceeding 8 mg per sq. cm.

Benalaxyl

Bendiocarb in preparations containing 2% or less of bendiocarb

Bentazone

Benzoyl peroxide, except—

(a)when included in Schedule 2, 3 or 4; or

(b)in preparations containing 2% or less of benzoyl peroxide

BHC (excluding lindane) in preparations containing 10% or less of BHC

Bioallethrin (including sinbioallethrin), except in preparations containing 10% or less of bioallethrin

Bioresmethrin, except in preparations containing 10% or less of bioresmethrin

Boric acid (excluding its salts) and borax, except—

(a)when included in Schedule 4;

(b)in preparations, other than insect baits, containing 1% or less of boron; or

(c)in hand cleaning preparations

Buthidazole

Butoxycarboxim in solid preparations containing 10% or less of butoxycarboxim

Cadmium sulphide in preparations containing 2.5% or less of cadmium sulphide for human therapeutic use

Calcium hypochlorite, except in preparations containing 4% or less of available chlorine

Camphor, except—

(a)when included in Schedule 4;

(b)when enclosed in an inhaler device which prevents ingestion of its contents; or

(c)in preparations containing 10% or less of camphor

Carbaryl—

(a)in preparations containing 10% or less of carbaryl, except when included in Schedule 2 or 4; or

(b)when impregnated into plastic resin material containing 20% or less of carbaryl

Chlorfenac

Chlorfenson

Chlorinated lime, except in preparations containing 4% or less of available chlorine

Chlorinating compounds, except—

(a)solid preparations containing 4% or less of available chlorine;

(b)liquid preparations containing not less than 2% but not more than 4% of available chlorine when labelled in letters not less than 2mm in height—

“WARNING—ENSURE ADEQUATE VENTILATION WHEN USING.  VAPOUR MAY BE HARMFUL.  MAY GIVE OFF DANGEROUS GAS IF MIXED WITH OTHER PRODUCTS”; or

(c)liquid preparations containing less than 2% of available chlorine

Chlornidine

Chlorocresol, except in preparations containing 3% or less of chlorocresol

Chlorpyrifos in preparations containing 5% or less of chlorpyrifos

Chlorsulfuron

Clanobutin for the treatment of animals, except when included in Schedule 4

Climbazole in preparations containing 40% or less of climbazole, except in preparations containing 2% or less of climbazole

Clofentezine

Clopyralid

Copper sulphate, except—

(a)in preparations for internal use; or

(b)in other preparations containing 5% or less of copper sulphate

4-CPA

Cuprimyxin for the treatment of animals

Cyanatryn

Cyanoacrylic esters in contact adhesives, except when labelled—

“KEEP OUT OF REACH OF CHILDREN.  AVOID CONTACT WITH SKIN AND EYES AND AVOID BREATHING VAPOUR.  BONDS ON CONTACT.  SHOULD FINGERS STICK TOGETHER APPLY A SOLVENT SUCH AS ACETONE TO CONTACT AREAS THEN WASH OFF WITH WATER.  DO NOT USE SOLVENTS NEAR EYES OR OPEN WOUNDS.  IN CASE OF EYE CONTACT IMMEDIATELY FLUSH WITH WATER.”

Cyanuric acid, excluding its salts and derivatives

Cyclohexanone peroxide

Cycloprothrin, except in preparations containing 10% or less of cycloprothrin

Cyfluthrin—

(a)in wettable powders containing 10% or less of cyfluthrin; or

(b)in emulsifiable concentrates containing 2% or less of cyfluthrin

Cypermethrin in preparations containing 10% or less of cypermethrin

2,4-D

2,4-DB

DDT in preparations containing 10% or less of DDT, except dicophane when included in Schedule 2

2,4-DES

Deltamethrin in aqueous formulations containing 1% or less of deltamethrin, when no organic solvent, other than a glycol, is present

N,N-Diallyldichloroacetamide, except in preparations containing 10% or less of N,N-diallyldichloroacetamide

Diazinon in dust preparations containing 2% or less of diazinon

Dicamba

Dichlofluanid

Dichlone

Dichloroisocyanurates, except in preparations containing 4% or less of available chlorine

Dichlorophen for the treatment of animals

2’,4’-Dichloro-2-(3-pyridyl)-acetophenone-O-methyloxime (pyrifenox)

Dichlorvos—

(a)when impregnated in plastic resin strip material containing 20% or less of dichlorvos;

(b)in sustained release resin pellets containing 20% or less of dichlorvos for the treatment of animals; or

(c)in pressurised spray packs containing 10 grams or less of dichlorvos

Diclobutrazol

Dicloran

Dicofol

Dicophane—see DDT

Diethyltoluamide, except in preparations containing 20% or less of diethyltoluamide when labelled—

“WARNING—THIS PRODUCT CONTAINS DIETHYLTOLUAMIDE, WHICH MAY BE DANGEROUS WHEN USED IN LARGE AMOUNTS OR FOR A LONG PERIOD”

Dimethirimol

Dimethylformamide in preparations containing 10% or less of dimethylformamide, except in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of dimethylformamide

Diniconazole

Diphenamid

Dodine

DSMA in herbicides or defoliant preparations containing 3% or less of arsenic

Enilconazole

Epoxy resins, liquid

EPTC

Ethephon, excluding its salts and derivatives

Ether in preparations containing more than 10% of ether for use in internal combustion engines

Ethofumesate

Ethoxyquin, except in preparations containing 10% or less of ethoxyquin

Ethylene glycol when packed and labelled as a boiling point or freezing point modifier containing not less than 10 mg/kg of denatonium benzoate as a bittering agent

Etridiazole

Fenarimol

Fenoprop

Fenoxaprop-ethyl

Fenson

Fenthion in preparations containing 25% or less of fenthion when packed in single-use containers having a capacity of 2 ml or less

Flamprop-methyl

Fluchloralin

Flumethrin in oil based preparations containing 1% or less of flumethrin

Fluorides (including silicofluorides) in preparations containing 0.5% or less of fluoride ion, except—

(a)in dentifrices containing 1000 mg/kg or less of fluoride ion; or

(b)in preparations containing 15 mg/kg or less of fluoride ion

Fluvalinate in aqueous preparations containing 25% or less of fluvalinate

Formic acid (excluding its salts and derivatives), except in preparations containing 0.5% or less of formic acid

Fospirate when impregnated in plastic resin strip material containing 20% or less of fospirate

Furalaxyl

Glufosinate-ammonium

Glutaraldehyde in preparations containing 5% or less of glutaraldehyde, except when included in Schedule 2

Glyphosate

Hexaconazole, except in preparations containing 5% or less of hexaconazole

Hexazinone

Hydramethylnone in solid baits containing 2% or less of hydramethylnone in welded plastic labyrinths

Hydrocarbons, liquid, (including kerosene, mineral turpentine, white petroleum spirit, toluene, xylene and light mineral and paraffin oils (but excluding their derivatives)) distilling under 300oC, except—

(a)toluene and xylene when included in Schedule 6;

(b)in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of liquid hydrocarbons;

(c)in solid or semi-solid preparations;

(d)in preparations containing 25% or less of liquid hydrocarbons;

(e)in preparations packed in pressurised spray packs; or

(f)in adhesives packed in containers each containing 50 grams or less of adhesive

Hydrochloric acid (excluding its salts and derivatives) in preparations containing 10% or less of hydrochloric acid (HC1), except—

(a)in preparations containing 0.5% or less of hydrochloric acid (HCl); or

(b)for therapeutic use

Hydrofluoric acid (including hydrosilicofluoric acid but excluding their salts and derivatives) in preparations containing the equivalent of 0.5% or less of hydrogen fluoride

Hydrogen peroxide (excluding its salts and derivatives), except in preparations containing 6% (20 vol) or less of hydrogen peroxide

Imazalil

Iodocarb, except in aqueous preparations containing 10% or less of iodocarb

Isophorone

Kerosene—see Hydrocarbons

Lead compounds in preparations for use as hair cosmetics

Levamisole in preparations containing 15% or less of levamisole for the treatment of animals, except when included in Schedule 4

Lindane in preparations containing 10% or less of lindane, except when included in Schedule 2 or 4

Maldison in preparations containing 10% or less of maldison, except—

(a)when included in Schedule 2 or 4; or

(b)in dust preparations containing 2% or less of maldison

Mancozeb

Maneb

MCPA

MCPB

Mecoprop

Mepiquat

Metalaxyl

Metaldehyde in preparations containing 2% or less of metaldehyde

Methabenzthiazuron

Methanol (excluding its derivatives) in preparations containing 10% cent or less of methanol, except—

(a)in preparations containing 2% or less of methanol; or

(b)in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of methanol

Methiocarb in pelleted preparations containing 2% or less of methiocarb

Methoxychlor

Methylated spirit (being ethanol denatured with denatonium benzoate, methyl isobutyl ketone and fluorescein) excluding its preparations and admixtures, except in containers having a capacity of more than 5 litres

Methylene chloride, except in pressurised spray packs other than when packed and labelled as degreasers, decarbonisers or paint strippers that contain more than 10% of methylene chloride

Methyl ethyl ketone, except—

(a)in preparations containing 25% or less of methyl ethyl ketone; or

(b)in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of methyl ethyl ketone

Methyl ethyl ketone peroxide

Methyl isoamyl ketone, except—

(a)in preparations containing 25% or less of methyl isoamyl ketone; or

(b)in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of methyl isoamyl ketone

Methyl isobutyl ketone, except—

(a)in preparations containing 25% or less of methyl isobutyl ketone; or

(b)in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of methyl isobutyl ketone

Methyl salicylate in liquid preparations containing 25% or more of methyl salicylate, except when included in Schedule 6

N-(3-Methyl-4-thiazolin-2-ylidene)-2,4-xylidene (cymiazole)

Metiram

Metolachlor

Metribuzin

Mezineb

Mineral turpentine—see Hydrocarbons

MSMA in herbicides or defoliant preparations containing 3% or less of arsenic

Myclobutanil

NAA, except in preparations containing 25% or less of NAA

Naled when impregnated in plastic resin strip material containing 20% or less of naled

Naphthalene

Naphthaleneacetic acid—see NAA

Naptalam

Nitric acid (excluding its salts and derivatives) in preparations containing 10% or less of nitric acid, except preparations containing 0.5% or less of nitric acid

Norbormide

Ofurace

Oxadixyl

Oxycarboxin

Oxythioquinox

Paclobutrazol

Paradichlorobenzene

Pebulate

Penconazole

Pendimethalin

Peracetic acid in concentrations of 10% or less of peracetic acid

Petrol, except—

(a)in preparations containing 25% or less of petrol; or

(b)in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of petrol

Phenisopham

Phenyl methyl ketone, except—

(a)in preparations containing 25% or less of phenyl methyl ketone; or

(b)in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of phenyl methyl ketone

ortho-Phenylphenol, except in preparations containting 5% or less of ortho-phenylphenol

Phosphonic acid (excluding its salts and derivatives), except in preparations containing 10% or less of phosphonic acid

Phosphoric acid (excluding its salts and derivatives), except—

(a)when packed in containers having a capacity of not less than 10 litres and labelled “CORROSIVE” in bold face sanserif capital letters of a height of not less than 1 cm;

(b)in preparations containing 350 g/litre or less of phosphoric acid;

(c)in solid and semi-solid preparations; or

(d)in professional dental kits

Pirimicarb in preparations containing 0.5% or less of pirimicarb

Poly (hexamethylene biguanide), except in preparations containing 5% or less of poly (hexamethylene biguanide)

Potassium chlorate, except—

(a)when included in Schedule 2; or

(b)in preparations containing 10% or less of potassium chlorate

Potassium hydroxide (excluding its salts and derivatives) in preparations containing 5% or less of potassium hydroxide, except in preparations containing 0.5% or less of potassium hydroxide

Potassium metabisulphite when packed for domestic use, except in preparations containing 10% or less of potassium metabisulphite

Potassium sulphide in preparations for metal treatment in containers each containing 50 g or less of potassium sulphide

Prometryn

Propamocarb

Propanil

Propiconazole in preparations containing 20% or less of propiconazole

Propionic acid (excluding its salts and derivatives) in preparations containing 80% or less of propionic acid, except—

(a)in preparations containing 30% or less of propionic acid; or

(b)for therapeutic use

Propoxur—

(a)in dust preparations containing 3% or less of propoxur;

(b)in granular sugar-based fly baits containing 1% or less of propoxur, where the preparation also contains a dark colouring agent and a separate bittering agent;

(c)in aerosol packs containing 10 g or less of propoxur; or

(d)in printed paper sheets for pest control containing 0.5% or less of propoxur and in any case not more than 100 mg of propoxur per sheet

Pyrethrins, naturally occurring, being pyrethrolone, cinerolone of jasmolone esters of chrysanthemic or pyrethric acids, except in preparations containing 10% or less of such substances

Quaternary ammonium compounds, except—

(a)when separately specified in these Schedules; or

(b)in preparations containing 10% or less of quaternary ammonium compounds

Quintozene

Salicylanilide

Selenium sulphide in preparations for topical therapeutic use containing 2.5% or less of selenium sulphide

Sethoxydim

Sodium chlorate, except in preparations containing 10% or less of sodium chlorate

Sodium hydrogen sulphate, except in preparations containing 10% or less of sodium hydrogen sulphate

Sodium hydroxide (excluding its salts and derivatives) in preparations containing 5% or less of sodium hydroxide, except in liquid preparations having a pH of 11.5 or less

Sodium hypochlorite, except in preparations containing 4% or less of available chlorine

Sodium metabisulphite when packed for domestic use, except in preparations containing 10% or less of sodium metabisulphite

Sodium nitrite, except—

(a)when included in Schedule 2; or

(b)in preparations containing 1% or less of sodium nitrite

Sodium sulphide—

(a)in preparations for metal treatment in containers each containing 50 g or less of sodium sulphide; or

(b)in preparations for use as insect lures

Styrene (excluding its derivatives), except in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of styrene

Sulfometuron-methyl

Sulphamic acid, except in preparations containing 10% or less of sulphamic acid 2,3,6-TBA

TCA— see Trichloroacetic acid

TDE (1,1-dichloro-2,2-bis(4-chlorophenyl)ethane) in preparations containing 10% or less of TDE

Temephos—

(a)in liquid preparations containing 10% or less of temephos; or

(b)in powders containing 2% or less of temephos

Terbutryn

Tetrachloroethylene in preparations containing 5% or less of tetrachloroethylene, except—

(a)when prepared for therapeutic use;

(b)when absorbed into an inert solid; or

(c)in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of tetrachloroethylene

Tetrachlorvinphos, except in animal feed containing 0.2% or less of tetrachlorvinphos

Tetramethrin (R,cis):(R,trans)=20:80, except in pressurised spray packs

Thifensulfuron

Thiobencarb

Tiocarbazil

Tolclofos-methyl

Tralkoxydim

Triadimefon in wettable powders containing 25% or less of triadimefon

Triadimenol

Tri-allate

Trichloroacetic acid, alkali salts of

1,1,1-Trichloroethane, except—

(a)in preparations packed in pressurised spray packs other than for therapeutic use;

(b)in preparations containing 25% or less of 1,1,1-trichloroethane;

(c)in preparations, other than writing correction fluids or thinners for writing correction fluids, in containers having a capacity of 50 ml or less;

(d)in writing correction fluids or thinners for writing correction fluids, in containers having a capacity of 50 ml or less labelled—

(i)“Trichloroethane” in letters not less than 1 mm in height and in distinct contrast to the background; and

(ii)“WARNING—DO NOT DELIBERATELY SNIFF THIS PRODUCT.  SNIFFING MIGHT HARM OR KILL YOU”, in bold sanserif capital letters not less than 1 mm in height and in a distinct contrast to the background; or

(e)in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of 1,1,1-trichloroethane

Trichloroisocyanuric acid in compressed block form for use in swimming pools or toilet cisterns

Tridiphane

Trietazine

Triflumizole

Triflumuron

Turpentine oil, except—

(a)in preparations containing 25% or less of turpentine oil; or

(b)in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of turpentine oil

Vernolate

Warfarin in rodent baits containing 0.1% or less of warfarin

Zineb

Ziram

SCHEDULE 6  Section 3

Acephate

Acetic acid (excluding its salts and derivatives) and preparations containing more than 80% of acetic acid, except when included in Schedule 2

Acetic anhydride, excluding its derivatives

Acifluorfen

Albendazole in preparations for the treatment of animals

Aldrin

Amidithion

2-Amino-butane

Aminocarb in preparations containing 25% or less of aminocarb

Amitraz

Ammonia (excluding its salts and derivatives other than ammonium hydroxide), except—

(a)when included in Schedule 5;

(b)in preparations for human internal therapeutic use;

(c)in preparations for inhalation when absorbed in an inert solid material; or

(d)in preparations containing 0.5% or less of ammonia

Aniline (excluding its salts and derivatives), except in preparations containing 1% or less of aniline

Antimony compounds, except—

(a)when included in Schedule 4;

(b)antimony chloride in polishes; or

(c)antimony titanate pigments in paint

Arecoline

Arsenic—

(a)in ant poisons containing 0.4% or less of arsenic;

(b)organic compounds of arsenic in herbicides or defoliant preparations, except when included in Schedule 5;

(c)in animal feed premixes containing 4% or less of arsenic;

(d)in preparations for the treatment of animals, except thiacetarsamide when included in Schedule 4; or

(e)in paints containing more than 0.1% of arsenic when calculated on the basis of the non-volatile content of the paint;

except when separately specified in this Schedule

Asprin for the treatment of animals, except when included in Schedule 4

Avermectin B1 in preparations containing 1% or less of avermectin B1, for the treatment of animals, when supplied in sealed containers for use in automatic injection equipment

Azaconazole, except in preparations containing 1% or less of azaconazole

Azobenzene

Bacitracin in animal feed premixes for growth promotion containing 2% or less of antibiotic substances

Barium salts, except—

(a)when included in Schedule 5;

(b)barium sulphate; or

(c)barium metaborate in paint

Bendiocarb—

(a)in wettable powders containing 80% or less of bendiocarb, when packed in containers or primary packs containing not less than 100 g of bendiocarb;

(b)in wettable powders containing 20% or less of bendiocarb and not less than 0.002% of denatonium benzoate, when packed in containers or primary packs containing not less than 48 g of bendiocarb and labelled for use as a fly control preparation; or

(c)in insoluble granular preparations containing 5% or less of bendiocarb;

except when included in Schedule 5

Benomyl

Benquinox

Bensulide

5-Benzylfur-3-ylmethyl (1’R,3’S.E)-2’,2’-dimethyl-3’-(2-oxo-2,3,4,5-tetrahydro-3-thienylidenemethyl)-cyclopropane carboxylate

Benzylpenicillin (including procaine penicillin) in preparations for intramammary infusion in animals containing not more than 100 000 I.U. of benzylpenicillin or procaine penicillin per dose, when packed in an applicator device specially designed for intramammary infusion and suitably coloured with no less than 25 mg per dose of Brilliant Blue FCF so that the visual end point excludes 95% of excreted antibiotic

Beryllium

BHC (excluding lindane), except when included in Schedule 5

Bithionol for treatment of animals

Brodifacoum in preparations containing 0.25% or less of brodifacoum

Bromadiolone in preparations containing 0.25% or less of bromadiolone

Bromethalin in rodent baits containing 100 mg/kg or less of bromethalin

Bromoform, exept when included in Schedule 4

Bromophos

Bromophos-ethyl

Bromoxynil

Brotianide

Bunamidine

Butacarb

Butoxycarboxim, exept when included in Schedule 5

2-Butoxy-2’-thiocyano-diethyl ether

Butynorate

Cacodylic acid in animal feed premixes containing 4% or less of arsenic

Cadmium compounds, except when included in Schedule 5

Cajuput oil, except in oils or preparations containing 25% or less of cineole

Calciferol in rodent baits containing 1 g/kg or less of calciferol

Cambendazole

Carbaryl, except when included in Schedule 2, 4 or 5

Carbendazim

Carbon disulphide

a-Chloralose—see Chloralose

Chloralose (a-chloralose) when packed and labelled for use as a pesticide

Chlordane

Chlorfenethol

Chlormequat

N-[5-Chloro-4-[(4-chlorophenyl)-cyanomethyl]-2-methylphenyl]-2-hydroxy-3, 5-diiodobenzamide

Chloroform, except—

(a)when included in Schedule 2 or 4; or

(b)in preparations containing 10% or less of chloroform

a-Chlorohydrin

Chlorophacinone

Chloropicrin in preparations containing 5% or less of chloropicrin

Chlorothalonil

Chlorpyrifos, except when included in Schedule 5

Chlorpyrifos-methyl

Chlortetracycline in preparations—

(a)for topical application to animals for ocular use only; or

(b)for intramammary infusion in animals containing not more than 100 000 I.U. of chlortetracycline per dose, when packed in an applicator device specially designed for intramammary infusion and suitably coloured with no less than 25 mg per dose of Brilliant Blue FCF so that the visual end point excludes 95% of excreted antibiotic

Chlorthiamid

Cholecalciferol in rodent baits containing 1 g/kg or less or cholecalciferol

Chromates (including dichromates), except chromates of barium, potassium, sodium, strontium, zinc or ammonia, in paint containing 5% or less of chromium, calculated on the non-volatile content of the paint

Chromium trioxide, excluding its salts and derivatives

Cineole, except in oils or preparations containing 25% or less of cineole

Climbazole, except—

(a)when included in Schedule 5; or

(b)in preparations containing 2% or less of climbazole

Clotrimazole for external treatment of animals

Coumaphos in preparations containing 5% or less of coumaphos

Coumatetralyl

Creosote, except—

(a)when included in Schedule 2; or

(b)in preparations containing 3% or less of phenols and homologues of phenol boiling below 220°C

Crotoxyphos

Crufomate

Cyanamide

Cyanazine

Cyfluthrin, except—

(a)when included in Schedule 5; or

(b)in pressurised spray packs  containing 1% or less of cyfluthrin

Cyometrinil

Cypermethrin, except when included in Schedule 5

Cythioate

Dazomet

DDT and its preparations, except—

(a)when included in Schedule 5; or

(b)dicophane included in Schedule 2

Demeton-O-methyl in preparations containing 10% or less of demeton-O-methyl, or of demeton-O-methyl and demeton-S-methyl

Demeton-S-methyl in preparations containing 10% or less of demeton-S-methyl, or of demeton-S-methyl and demeton-O-methyl

Diazinon, except when included in Schedule 5

trans-4-((3,5-Dibromo-2-hydroxybenzyl)-amino) cyclohexanol hydrochloride monohydrate (sputolysin) in oral preparations for the treatment of animals

Dichlofenthion

ortho-Dichlorobenzene

Dichloroethyl ether

Dichlorophen, except when included in Schedule 5

1,2-Dichloropropane

Dichlorvos in preparations containing 50% or less of dichlorvos, except when included in Schedule 5

Diclofop-methyl

Dicophane—see DDT

Dieldrin

Difenacoum in preparations containing 0.25% or less of difenacoum

Difenzoquat

Dihydrostreptomycin in preparations for intramammary infusion in animals containing not more than 100 000 I.U. of dihydrostreptomycin per dose, when packed in an applicator device specially designed for intramammary infusion and suitably coloured with no less    than 25 mg per dose of Brilliant Blue FCF so that the visual end point excludes 95% of excreted antibiotic

Dimethipin

Dimethoate

1,3-Di(methoxycarbonyl)-1-propen-2-yl-dimethyl phosphate in preparations containing 25% or less of 1,3-di(methoxycarbonyl)-1-propen-2-yl-dimethyl phosphate

Dimethylformamide, except—

(a)when included in Schedule 5; or

(b)in containers having a capacity of more than 25 litres which are labelled “POISON” and state the proportion of dimethylformamide

Dimethyl sulphoxide—

(a)when not for therapeutric use; or

(b)for the treatment of animals—

(i)when combined with no other therapeutic substance; or

(ii)in preparations containing copper salicylate as the only other therapeutic substance

Dinitrocresols and their homologues, in preparations containing 5% or less of such compounds, except—

(a)when included in Schedule 4; or

(b) when separately specified in this Schedule

Dinitrophenols and their homologues, in preparations containing 5% or less of such compounds, except—

(a)when included in Schedule 4; or

(b)when separately specified in this Schedule

Dinocap

Dioxacarb

Dioxane

Diphacinone

Diquat

Disulfiram, except when included in Schedule 4

Disulfoton in granular preparations containing 5% or less of disulfoton

Dithianon

Dithiazanine in preparations containing 2% or less of dithiazanine, for the treatment of animals

Dithiocarbamates when prepared for agricultural, horticultural or pastoral purposes, except when separately specified in this Schedule or in Schedule 5

Diuredosan

DSMA in herbicides or defoliant preparations, except when included in Schedule 5

Econazole for the external treatment of animals

Endosulfan

Endothal in preparations containing 20% or less of endothal

Erythromycin—

(a)in preparations for intramammary infusion in animals containing not more than 100 000 I.U. of erythromycin per dose, when packed in an applicator device specially designed for intramammary infusion and suitably coloured with no less than 25 mg per dose of Brilliant Blue FCF so that the visual end point excludes 95% of excreted antibiotic; or

(b)in animal feed premixes for growth promotion containing 2% or less of antibiotic substances

Esfenvalerate

Ether, except—

(a)when included in Schedule 2, 4 or 5; or

(b)in preparations containing 10% or less of ether

Ethiofencarb

Ethoate-methyl

Ethoprophos in granular formulations containing 10% or less of ethoprophos and 2% of linseed oil

Ethyl bromide

Ethyl-2-[4-(6-chloro-2-quinoxalyloxy)phenoxy] propionate (quizalofop ethyl)

Ethylene chlorohydrin

Ethylene dichloride

Ethylene glycol when packed and labelled as a boiling point or freezing point modifier, except when included in Schedule 5

Ethylene glycol monoalkyl ethers and their acetates, except—

(a)in preparations containing 10% or less of such substances; or

(b)in containers having a capacity of 25 litres or more which are labelled “POISON”, the name and quantity of the ether, the name of the manufacturer or the trade mark and the statement “Avoid contact with skin and eyes and avoid breathing the vapour”

Etrimfos

Eucalyptus oil, except in preparations containing 25% or less of eucalyptus oil

Famphur in preparations containing 20% or less of famphur

Fenaminosulf in preparations containing 10% or less of fenaminosulf when labelled and packed as dry seed dressings

Fenamiphos in granular preparations containing 5% or less of fenamiphos

Fenazaflor

Fenbutatin-oxide

Fenchlophos

Fenitrothion

Fenoxacarim in preparations for the treatment of carpets during manufacture

Fenthion, except when included in Schedule 5

Fenvalerate

Ferbam

Flavophospholipol in animal feed premixes for growth promotion containing 2% or less of antibiotic substances

Fluazifop-butyl

Fluazifop-p-butyl

Flucofuron in preparations for the treatment of carpets during manufacture

Flumethrin, except when included in Schedule 5

Fluorides (including silicofluorides), except—

(a)when included in Schedule 2, 3, 4 or 5;

(b)in preparations containing 3% or less of sodium fluoride or sodium silicofluoride as preservative;

(c)in pesticide preparations containing 3.2% or less of ammonium silicofluoride;

(d)in dentifrices containing 1000 mg/kg or less of fluoride ion; or

(e)in preparations containing 15 mg/kg or less of fluoride ion

Flusilazol

Flutriafol, except in fertilizers containing 0.5% or less of flutriafol

Fluvalinate, except when included in Schedule 5

Formaldehyde (excluding its derivatives other than paraformaldehyde), except in preparations containing 5% or less of formaldehyde

Formathion

Fospirate, except when included in Schedule 5

Fumagillin

Glutaraldehyde, except when included in Schedule 2 or 5

Glyceryl thioglycollate in hair waving preparations, unless the directions for use include the statement—

“WEAR PROTECTIVE GLOVES WHEN USING.  KEEP OUT OF EYES.”

Guazatine

Haloxon

Haloxyfop

Heptachlor

Hexachlorophane in preparations for the treatment of animals

Hydramethylnone, except when included in Schedule 5

Hydrazine

Hydrochloric acid (excluding its salts and derivatives), except in preparations containing 10% or less of hydrochloric acid (HCl)

Hydrofluoric acid (including hydrosilicofluoric acid but excluding their salts and derivatives) in preparations containing the equivalent of 10% or less of hydrogen flouride, except when included in Schedule 5

Hydroquinone, except—

(a)when included in Schedule 2 or 4; or

(b)in preparations containing 10% or less of hydroquinone

Hydrosilicofluoric acid—see Hydrofluoric acid

Hygromycin for use as an anthelmintic in animal feed premixes containing 2% or less of antibiotic substances

Imidocarb

Iodine (excluding its salts, derivatives and iodophors), except—

(a)when included in Schedule 2; or

(b)in solid or semi-solid preparations containing 2.5% or less of available iodine

Iodophors, except in preparations containing 1.5% or less of available iodine

Ioxynil

Iron compounds for the treatment of animals, except—

(a)in liquid or gel preparations containing 0.1% or less of iron; or

(b)in animal feeds and feed premixes

Isoconazole for the external treatment of animals

Isocyanates, free organic

Ivermectin—

(a)in preparations containing 0.8 g/litre of ivermectin for the treatment of sheep;

(b)in pre-loaded syringes containing 10 g or less of a paste containing 2% or less of ivermectin for the treatment of horses; or

(c)in preparations containing 1% or less of ivermectin, for the treatment of bovine cattle, when supplied in sealed containers for use in automatic injection equipment

Kitasamycin in animal feed premixes for growth promotion containing 2% or less of antibiotic substances

Lasalocid, except in animal feeds containing 100 mg/kg or less of antibiotic substances

Laurylisoquinolinium bromide

Lead compounds, except—

(a)when included in Schedule 4 or 5;

(b)in preparations for cosmetic use containing 100 mg/kg or less of lead; or

(c)in pencil cores, finger colours, showcard colours, pastels, crayons, poster paints, poster colours or coloured chalks when these products contain 100 mg/kg or less of lead

Levamisole for the treatment of animals, except—

(a)when included in Schedule 4 or 5; or

(b)in preparations for the treatment of ornamental birds or ornamental fish in packs containing 10 mg or less of levamisole

Lindane, except when included in Schedule 2, 4 or 5

Maduramicin in animal feed premixes containing 1% or less of antibiotic substances

Mafenide for the treatment of aquarium fish

Maldison, except—

(a)when included in Schedule 2, 4 or 5; or

(b)in dust preparations containing 2% or less of maldison

Mebendazole for the treatment of animals

Meclofenamic acid for the treatment of animals

Mefluidide

Melaleuca oil (tea-tree oil), except in preparations containing 25% or less of melaleuca oil

Menazon

Mercuric oxide for the treatment of animals, in preparations for ocular use

Mercuric thiocyanate when prepared for use for photographic purposes

Mercurochrome for the treatment of animals, in preparations for topical use

Metacresolsulphonic acid and formaldehyde condensation product for the treatment of animals

Metaldehyde, except when included in Schedule 5

Metham

Methanol (excluding its derivatives), except—

(a)when included in Schedule 5; or

(b)in preparations containing 2% or less of methanol

Methazole

Methiocarb, except when included in Schedule 5

Methomyl in fly-baits containing 1% or less of methhomyl and not less than 0.002% of denatonium benzoate as a bittering agent

Methyl chloride

Methylenebisthiocyanate, except in preparations containing 1% or less of methylenebisthiocyanate

Methyl isothiocyanate

Methyl salicylate excluding admixtures

Miconazole for the external treatment of animals

Molinate

Monensin—

(a)in animal feed premixes for growth promotion or for coccidiosis prevention containing 12.5% or less of monensin; or

(b)in intraruminal implants for cattle each containing 35 g or less of monensin

MSMA in herbicides or defoliant preparations, except when included in Schedule 5

Nabam

Naled, except when included in Schedule 5

Nalidixic acid when packed and labelled for the treatment of ornamental fish

Naphthalophos when specifically prepared and packed for use as a sheep drench

Narasin in animal feed premixes containing 120 g/kg or less of narasin

Neomycin in preparations for topical application to animals for ocular use only

Nicotine in preparations containing 3% or less of nicotine, when packed and labelled for the treatment of animals

Nimidane in preparations containing 25% or less of nimidane

Nithiamide, except in preparations containing 20% or less or nithiamide

Nitric acid (excluding its salts and derivatives), except in preparations containing 10% or less of nitric acid as such

Nitrobenzene, except—

(a)in solid or semi-solid polishes;

(b)in soaps containing 1% or less of nitrobenzene; or

(c)in other preparations containing 0.1% or less of nitrobenzene

Nitrophenols, ortho, meta and para

Nitroscanate

Nitroxynil

Novobiocin in preparations for intramammary infusion in animals containing not more than 100 000 I.U. of novobiocin per dose, when packed in an applicator device specially designed for intramammary infusion and suitably coloured with no less than 25 mg per dose of Brilliant Blue FCF so that the visual end point excludes 95% of excreted antibiotic

Ochtilinone—see 2-Octyl-4-isothiazolin-3-one

2-Octyl-4-isothiazolin-3-one (octhilinone)

Oestradiol—

(a)in ear implants for growth promotion in bovine cattle; or

(b)in combination with progesterone, testosterone or trenbolone in ear implants for growth promotion in bovine cattle

Olaquindox in animal feed premixes for growth promotion

Oleandomycin in animal feed premixes for growth promotion containing 2% or less of antibiotic substances

Omethoate in preparations containing 50% or less of omethoate

Organo-tin compounds—see Tin organic compounds

Oxadiazon

Oxalic acid, except its derivatives and insoluble salts

Oxantel embonate for the treatment of animals

Oxfendazole

Oxyclozanide

Oxytetracycline in preparations—

(a)for topical application to animals for ocular use only; or

(b)for intramammary infusion in animals containing not more than 100 000 I.U. of oxytetracycline per dose, when packed in an applicator device specially designed for intramammary infusion and suitably coloured with no less than 25 mg per dose of Brilliant Blue FCF so that the visual end point excludes 95% of excreted antibiotic

Parbendazole

Pentachlorophenol, except in preparations containing 0.5% or less of pentachlorophenol

Peracetic acid, except when included in Schedule 5

Perfluidone

Permanganates

Phenethicillin in preparations for intramammary infusion in animals containing not more than 100 000 I.U. of phenethicillin per dose, when packed in an applicator device specially designed for intramammary infusion and suitably coloured with no less than 25 mg per dose of Brilliant Blue FCF so that the visual end point excludes 95% of excreted antibiotic

Phenol, or any homologue of phenol boiling below 220°C, except—

(a)when included in Schedule 2; or

(b)in preparations containing 3% or less of such substances

Phenothiazine (excluding its derivatives), except in preparations containing 10% or less of phenothiazine

Phenoxymethylpenicillin in preparations for intramammary infusion in animals containing not more than 100 000 I.U. of phenoxymethylpenicillin per dose, when packed in an applicator device specially designed for intramammary infusion and suitably coloured with no less than 25 mg per dose of Brilliant Blue FCF so that the visual end point excludes 95% of excreted antibiotic

Phenylenediamines and alkylated phenylenediamines not elsewhere specified in this Schedule or in Schedule 2—

(a)when used in hair dyes;

(b)in preparations packed and labelled for photographic purposes; or

(c)in preparations packed and labelled for testing water, except in tablets containing 10 mg or less of diethyl-para-phenylenediamine or dimethyl-para-phenylenediamine in opaque strip packaging provided the directions for use include the statement—

“DO NOT DISCARD TESTING SOLUTIONS INTO THE POOL”

Phosalone

Phosmet

Phosphides, metallic

Phoxim

Picric acid (excluding its derivatives), except in preparations containing 5% or less of picric acid

Pindone

Piperophos

Pirimicard, except when included in Schedule 5

Pirimiphos-ethyl

Pirimiphos-methyl

Potassium bromate, except in preparations containing 0.5% or less of potassium bromate

Potassium cyanate

Potassium hydroxide (excluding its salts and derivatives), except—

(a)when included in Schedule 5; or

(b)in preparations containing 0.5% or less of potassium hydroxide

Prochloraz

Profenofos

Progesterone—

(a)in a silicone rubber elastomer when used as a controlled-release implant for synchronisation of oestrus in cattle; or

(b)in combination with oestradiol or trenbolone, in ear implants for growth promotion in bovine cattle

Promacyl

Promecarb in preparations containing 50% or less of promecarb

Propachlor

Propargite

Propetamphos

Propiconazole, except when included in Schedule 5

Propineb

Propionic acid (excluding its salts and derivatives), except—

(a)when included in Schedule 5;

(b)in preparations containing 30% or less of propionic acid; or

(c)for therapeutic use

Propoxur, except when included in Schedule 4 or 5

Propylene oxide in preparations containing 4% or less of propylene oxide

Prothiofos

Pyrazophos

Rafoxanide

Salinomycin in animal feed premixes containing 6% or less of antibiotic substances

Selenium—

(a)in preparations containing 2.5% or less of selenium when packed and labelled—

(i)for the blueing of gun barrels; or

(ii)for photographic purposes;

(b)in coated fertiliser granules containing 1% or less of selenium, except in fertilisers containing 200 g/tonne or less of selenium;

(c)in a drench, injection, paste, stock lick or vaccine containing 0.5% or less of selenium for the treatment of animals; or

(d)in animal feed premixes containing 2% or less of selenium for the preparation of feeds containing 0.1 g/tonne or less of selenium

Silver nitrate, except—

(a)when included in Schedule 2; or

(b)in chewing tablets

Sodium bromate, except in preparations containing 0.5% or less of sodium bromate

Sodium hydroxide (excluding its salts and derivatives), except—

(a)when included in Schedule 5; or

(b)in preparations containing 0.5% or less of sodium hydroxide

Spiramycin in animal feed premixes for growth promotion containing 2% or less of antibiotic substances

Streptomycin in preparations for intramammary infusion in animals containing not more than 100 000 I.U. of streptomycin per dose, when packed in an applicator device specially designed for intramammary infusion and suitably coloured with no less than 25 mg per dose of Brilliant Blue FCF so that the visual end point excludes 95% of excreted antibiotic

Sulcofuron in preparations for the treatment of carpets during manufacture

Sulphaquinoxaline when packed and labelled for use as a coccidiostat in poultry, except preparations containing 200 mg/kg or less of sulphaquinoxaline

Sulphonamides when packed and labelled for the treatment for ornamental caged birds or ornamental fish only

Sulphuric acid (excluding its salts and derivatives), except—

(a)in fire extinguishers; or

(b)in preparations containing 0.5% or less of sulphuric acid

Sulprophos

2,4,5-T

TCA—see Trichloroacetic acid

TCMTB (2-[thiocyanomethylthio]benzothiazole)

TDE (1,1-dichloro-2,2-bis(4-chlorophenyl)ethane), except when included in Schedule 5

Tea-tree oil—see Melaleuca oil

Temephos, except when included in Schedule 5

Terbuthylazine

Terpenes, chlorinated

Testosterone—

(a)testosterone cypionate, dipropionate, enanthate and propionate in preparations labelled for treatment and prevention of pizzle (sheath) rot in wethers;

(b)in preparations labelled for masculinisation of wethers for use as ‘teaser rams’ to stimulate and detect reproductive activity in ewes;

(c)in combination with oestradiol or trenbolone in ear implants for growth promotion in bovine cattle; or

(d)in oil preparations for growth promotion purposes labelled for injection at the base of the ear in sheep

Tetrachloroethylene, except—

(a)when included in Schedule 5;

(b)in preparations containing 6% or less of tetrachloroethylene when absorbed into an inert solid;

(c)for therapeutic use; or

(d)in containers having a capacity of more than 25 litres which are labelled “POISON” and state the proportion of tetrachloroethylene

Tetracycline in preparations—

(a)for topical application to animals for ocular use only;

(b)for intramammary infusion in animals containing not more than 100 000 I.U. of tetracycline per dose, when packed in an applicator device specially designed for intramammary infusion and suitably coloured with no less than 25 mg per dose of Brilliant Blue FCF so that the visual end point excludes 95% of excreted antibiotic; or

(c)when packed and labelled for treatment of ornamental caged birds or ornamental fish only

Tetradifon

2,2’,6,6’-Tetraisopropyl-diphenyl-carbodiimide in amitraz formulations containing 2% or less of 2,2’,6,6’-tetraisopropyl-diphenyl-carbodiimide

2,2,3,3-Tetrafluoropropionic acid (flupropanate)

Tetramisole in preparations for the treatment of animals

Thiazafluron

Thiodicarb

Thiometon

Thiourea and alkyl thioureas, except for therapeutic use

Thiram

Tiamulin for the treatment of animals—

(a)in feed premixes containing 25% or less of tiamulin; or

(b)in soluble concentrates containing 45% or less of tiamulin

Tin organic compounds, being di-alkyl, tri-alkyl and tri-phenyl tin compounds where the alkyl group is methyl, ethyl, propyl or butyl, except—

(a)when separately specified in this Schedule;

(b)in plastics; or

(c)in paints containing 1% or less of tin

Toluene (excluding its derivatives), except—

(a)in preparations containing 50% or less of toluene or toluene and xylene; or

(b)in containers having a capacity of more than 25 litres which are labelled “POISON” and state the proportion of toluene or toluene and xylene

Trenbolone—

(a)in ear implants for growth promotion in bovine cattle; or

(b)in combination with oestradiol, progesterone or testosterone in ear implants for growth promotion in bovine cattle

Triadimefon, except—

(a)when included in Schedule 5; or

(b)in fertilisers containing 5 g/kg or less of triadimefon

Trichlorfon

Trichloroacetic acid, except when included in Schedule 5

Trichloroethylene, except when included in Schedule 4

Trichlorophenol

Triclopyr

Tridemorph

Triethyl phosphate

Trifluoromethane sulphonic acid

Tylosin in animal feed premixes for growth promotion containing 5% or less of antibiotic substances

Vamidothion

Virginiamycin in animal feed premixes for growth promotion containing 2% or less of antibiotic substances

Warfarin, except—

(a)when included in Schedule 4 or 5; or

(b)for external therapeutic use

Xylene (excluding its derivatives), except—

(a)in preparations containing 50% or less of xylene or xylene and toluene; or

(b)in containers having a capacity of more than 25 litres which are labelled “POISON” and state the proportion of xylene or xylene and toluene

Zeranol in ear implants for use as a growth promotant in steer cattle

Zinc chloride, except in preparations containing 5% or less of zinc chloride

Zinc p-phenolsulphonate, except in preparations containing 5% or less of zinc p‑phenolsulphonate

Zinc sulphate, except—

(a)when included in Schedule 4;

(b)in preparations for human internal use with a recommended daily dose of 50 mg or less of zinc; or

(c)in other preparations containing 5% or less of zinc sulphate

SCHEDULE 7  Section 3

Acrolein

Acrylonitrile

Alachlor

Aldicarb

Aldoxycarb

Allyl alcohol

Aminocarb, except when included in Schedule 6

4-Aminopyridine, except when included in Schedule 4

Amiton

Arprinocid

Arsenic, except—

(a)thiacetarsamide when included in Schedule 4;

(b)when included in Schedule 5 or 6;

(c)selenium arsenide in photocopier drums; or

(d)in animal feeds containing 75 g/tonne or less of arsenic

Avermectin B1, except when included in Schedule 6

Azinphos-ethyl

Azinphos-methyl

Azocyclotin

Bendiocarb, except when included in Schedule 5 or 6

Benzene (excluding its derivatives), except—

(a)preparations containing 15 ml/litre or less of benzene; or

(b)petrol containing 50 ml/litre or less of benzene

Brodifacoum, except when included in Schedule 6

Bromadiolone, except when included in Schedule 6

Bromethalin, except when included in Schedule 6

Bromine, excluding its salts and derivatives

Brucine, except when used in concentrations of 0.02% or less for the denaturation of alcohol

Calciferol for use as a rodenticide, except when included in Schedule 6

Captafol

Captan

Carbadox

Carbofuran

Carbon tetrachloride, except in chlorinated rubber based paints containing less that 1% of carbon tetrachloride

Carbophenothion

Chlordecone

Chlordimeform

Chlorfenvinphos

Chlorine, excluding its salts and derivatives

Chloromethiuron

5-Chloro-3-methyl-4-nitropyrazole

4-Chloro-o-toluidine

Chloropicrin, except when included in Schedule 6

Chlorthiophos

Cholecalciferol for use as a rodenticide, except when included in Schedule 6

Coumaphos, except when included in Schedule 6

Cyanides, except—

(a)ferricyanides; or

(b)ferrocyanides

Cyhalothrin

Cyhexatin

Deltamethrin, except when included in Schedule 5

Demeton

Demeton-O-methyl, except when included in Schedule 6

Demeton-S-methyl, except when included in Schedule 6

Dialifos

4,4-Diaminodiphenylmethane (methylene dianiline)

1,2-Dibromo-3-chloropropane

1,3-Dichloropropene

Dichlorvos, except when included in Schedule 5 or 6

Dicrotophos

Dienochlor

Difenacoum, except when included in Schedule 6

Dimefox

1,3-Di (methoxycarbonyl)-1-propen-2-yl-dimethyl phosphate, except when included in Schedule 6

N,N-Dimethyl-4-(phenylazo)-benzamine

Dimethyl sulphate

Dimetilan

Dinitrocresols, except when included in Schedule 4 or 6

Dinitrophenols, except when included in Schedule 4 or 6

Dinoseb

Disulfoton, except when included in Schedule 6

Endothal, except when included in Schedule 6

Endrin

Epichlorohydrin

Etaconazole

Ethion

Ethoprophos, except when included in Schedule 6

Ethylene dibromide

Ethylene oxide

Famphur, except when included in Schedule 6

Fenaminosulf, except when included in Schedule 6

Fenamiphos, except when included in Schedule 6

Fenoxacarim, except—

(a)when included in Schedule 6; or

(b)in treated carpets

Fensulfothion

Fenthion-ethyl

Flucofuron, except—

(a)when included in Schedule 6; or

(b)in treated carpets

Flucythrinate

Fluoroacetamide

Fluoroacetic acid

Folpet

Formetanate

Halofuginone, except in prepared stockfeeds containing 3 g/tonne or less of halofuginone

Halogenated dibenzodioxins and dibenzofurans

HCB

Hydrocarbons liquid aromatic (including aromatic extract oils), any fraction of which boils above 350°C, except when in solid polymers

Hydrocyanic acid (excluding its salts and derivatives), except when included in Schedule 4

Hydrofluoric acid (including hydrosilicofluoric acid but excluding their salts and derivatives), except when included in Schedule 5 or 6

Hydrogen sulphide

Isocarbophos

Isofenphos

Ivermectin, except when included in Schedule 4 or 6

Leptophos

Maduramicin, except when included in Schedule 6

Mazidox

Mecarbam

Mercuric chloride when prepared for use for agricultural, industrial, pastoral or horticultural purposes

Mercury, except—

(a)when separately specified in this Schedule;

(b)when included in Schedule 2, 4 or 6;

(c)in preparations containing 0.01% or less of mercury in organic form as a preservative;

(d)mercury (metallic) in scientific instruments; or

(e)dental amalgams

Methacrifos

Methamidophos

Methapyrilene

Methidathion

Methomyl, except when included in Schedule 6

Methyl bromide

4,4´-Methylenebis[2-chloroaniline] (MOCA)

Mevinphos

Mipafox

Mirex

Monocrotophos

Naphthalophos, except when included in Schedule 6

Nicotine, except—

(a)when included in Schedule 3, 4 or 6; or

(b)in tobacco prepared and packed for smoking

Nimidane, except when included in Schedule 6

Nitrofen

Omethoate, except when included in Schedule 6

Oxamyl

Oxyfluorfen

Paraquat

Parathion

Parathion-methyl

Phorate

Phosfolan

Phosphine

Phosphorus, yellow (excluding its salts and derivatives)

Polychlorinated biphenyls

Promecarb, except when included in Schedule 6

Propylene oxide, except when included in Schedule 6

Pyrinuron

Schradan

Selenium, except—

(a)when included in, or expressly excluded from, Schedule 4, 5 or 6; or

(b)as selenium arsenide in photocopier drums

Strychnine (including Nux vomica), except when included in Schedule 4

Sulcofuron, except—

(a)when included in Schedule 6; or

(b)in treated carpets

Sulfotep

TEPP

Terbufos

Tetrachloroethane

2,2´, 6,6´-Tetraisopropyl-diphenyl-carbodiimide, except when included in Schedule 6

Thallium

Thiofanox

ortho-Tolidine

Triamiphos

Triazbutil

Trichloroisocyanuric acid, except—

(a)when included in Schedule 5; or

(b)in preparations containing 4% or less of available chlorine

Vinyl chloride

NOTE

1. Ordinance No. 38, 1978 as amended by Nos. 19 and 56, 1981; No. 47, 1982; No. 67, 1985; Nos. 32 and 76, 1986; No. 29, 1988; Nos. 13, 21 and 38, 1989.

[Presentation speech made in Assembly on 13 December 1990.]

©  Australian Capital Territory 1991